<SEC-DOCUMENT>0001140361-21-028297.txt : 20210813
<SEC-HEADER>0001140361-21-028297.hdr.sgml : 20210813
<ACCEPTANCE-DATETIME>20210813170612
ACCESSION NUMBER:		0001140361-21-028297
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20210813
DATE AS OF CHANGE:		20210813

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brooklyn ImmunoTherapeutics, Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-258816
		FILM NUMBER:		211173250

	BUSINESS ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALROY INDUSTRIES INC
		DATE OF NAME CHANGE:	19850411
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>ny20000330x1_s-3.htm
<DESCRIPTION>S-3
<TEXT>
<html><head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.5.1.0
         Copyright 1995 - 2021 Broadridge -->
  </head><body style="color: #000000;" bgcolor="#ffffff">
<!--Begin Page 1-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 540pt;"><a name="ny20000330x1_s-3_100-regcov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 540pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 25pt; text-align: center;">As filed with the Securities and Exchange Commission on August&#160;13, 2021</div><div class="regno" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 1pt; text-align: right;">Registration No. 333-&#8195;&#8195;&#8195; </div></div></div><div class="block-frill" style="width: 540pt; margin-left: 0pt;"><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="block-main" style="width: 540pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 8pt; text-align: center;">UNITED STATES SECURITIES AND EXCHANGE COMMISSION<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-size: 10pt;">WASHINGTON, D.C. 20549</font></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 18.5pt; text-align: center;">FORM S-3<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-size: 10pt;">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</font></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 18.5pt; text-align: center;">BROOKLYN IMMUNOTHERAPEUTICS, INC.<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-size: 10pt; font-style: italic; font-weight: normal;">(Exact name of registrant as specified in its charter)</font></div><table cellspacing="0" cellpadding="0" class="txttab" style="margin-top: 4pt; border-collapse: collapse; width: 540pt; margin-left: auto; margin-right: auto;"><tr><td style="width: 48.89%; text-align: center; vertical-align: top; padding-top: 6pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Delaware </div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 48.89%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">31-1103425 </div></td></tr><tr><td style="width: 48.89%; text-align: center; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-style: italic; margin-top: 0pt; text-align: center;">(State or other jurisdiction of incorporation or organization<font style="font-style: normal;">)</font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 48.89%; text-align: center; vertical-align: bottom; padding-top: 2pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-style: italic; margin-top: 0pt; text-align: center;">(I.R.S. Employer Identification Number)</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 2.5pt; text-align: center;">140 58th Street, Suite 2100<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Brooklyn, New York 11220<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">(212) 582-1199<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-style: italic; font-weight: normal;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 2.5pt; text-align: center;">Howard J. Federoff<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Chief Executive Officer and President<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Brooklyn ImmunoTherapeutics, Inc.<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">140 58th Street, Suite 2100, Brooklyn, New York 11220<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">(212) 582-1199<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-style: italic; font-weight: normal;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-style: italic; margin-top: 2.5pt; text-align: center;">Copies to:<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-style: italic; margin-top: 0pt; text-align: center;"><font style="font-style: normal; font-weight: bold;">Mark L. Johnson</font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-style: italic; margin-top: 0pt; text-align: center;"><font style="font-style: normal; font-weight: bold;">Bella Zaslavsky</font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-style: italic; margin-top: 0pt; text-align: center;"><font style="font-style: normal; font-weight: bold;">K&amp;L Gates LLP</font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-style: italic; margin-top: 0pt; text-align: center;"><font style="font-style: normal; font-weight: bold;">One Lincoln Street, Boston, Massachusetts 02111</font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-style: italic; margin-top: 0pt; text-align: center;"><font style="font-style: normal; font-weight: bold;">(617) 261-3100</font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 2.5pt; margin-left: 0pt; text-align: left;">Approximate date of commencement of proposed sale to the public: <font style="font-weight: normal;">From time to time after this registration statement is declared effective.</font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 2pt; margin-left: 0pt; text-align: justify;">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. <font style="font-size: 1pt;">&#8201;</font>&#x2610;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 2pt; margin-left: 0pt; text-align: justify;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. &#x2611;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 2pt; margin-left: 0pt; text-align: justify;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font>&#x2610;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 2pt; margin-left: 0pt; text-align: justify;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font>&#x2610;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 2pt; margin-left: 0pt; text-align: justify;">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective on filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. <font style="font-size: 1pt;">&#8201;</font>&#x2610;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 2pt; margin-left: 0pt; text-align: justify;">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. <font style="font-size: 1pt;">&#8201;</font>&#x2610;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 2pt; margin-left: 0pt; text-align: justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div><table cellspacing="0" cellpadding="0" class="txttab" style="margin-top: 4pt; border-collapse: collapse; width: 540pt; margin-left: auto; margin-right: auto;"><tr><td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Large accelerated filer</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 33.33%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9pt;">&#x2610;</font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 22.22%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accelerated filer</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 4.44%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9pt;">&#x2610;</font></div></td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-accelerated filer</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 33.33%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#x2611;</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 22.22%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Smaller reporting company</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 4.44%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#x2611;</div></td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt;">&#160;</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 33.33%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt;">&#160;</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 22.22%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Emerging growth company</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.44%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9pt;">&#x2610;</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 2pt; margin-left: 0pt; text-align: justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <font style="font-size: 1pt;">&#8201;</font>&#x2610;</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8pt; text-align: center;">CALCULATION OF REGISTRATION FEE</div><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 1pt;"> </div></div><table cellspacing="0" cellpadding="0" class="regtab" style="margin-top: 4pt; border-collapse: collapse; width: 540pt; margin-left: auto; margin-right: auto; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000;"><tr class="header"><td style="width: 33.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Title of Each Class of Securities to be Registered</div></td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 11.11%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount to be Registered<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 18.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Proposed Maximum <br></div><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Offering Price Per <br></div><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Share<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div></td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 18.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Proposed Maximum <br></div><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate Offering <br></div><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div></td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 13.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 3.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount of <br></div><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Registration Fee</div></td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Common stock, par value $0.005 per share<font style="padding-left: 3.84pt;"></font></div></td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 11.11%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 12pt; text-align: left;">6,281,454</div></td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 18.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 38.79pt; text-align: left;">$11.69</div></td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 18.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 22.88pt; text-align: left;">$73,430,197.16</div></td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 13.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 18.16pt; text-align: left;">$8,011.23</div></td></tr></table><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 3pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 2pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The shares will be offered for resale by the selling stockholders. Pursuant to Rule 416 under the Securities Act of 1933, this registration statement also covers any additional number of shares of common stock issuable upon stock splits, stock dividends, dividends or other distribution, recapitalization or similar events with respect to the shares of common stock being registered pursuant to this registration statement.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 2pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, based on the average of the high and low prices per share of common stock as reported on the NYSE American on August&#160;12, 2021.</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 2pt; margin-left: 0pt; text-align: justify;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.</div></div><div class="block-frill" style="width: 540pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 1-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 2-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 456pt;"><a name="ny20000330x1_s-3_101-cov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 456pt; margin-left: 0pt;"><div class="h1" style="color: #FC0014; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><div style="font-family: Arial, Helvetica, sans-serif; text-align: left; margin-bottom: 12pt;">The information in this prospectus is not complete and may be changed. The securities may not be sold until the registration statement filed with the Securities and Exchange Commission is declared effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</div>Subject to Completion, dated August&#160;13, 2021</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">PROSPECTUS</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.25pt; text-align: center;"><img style="height: 108px; width: 425px;" src="logo_brooklyn.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 20.5pt; text-align: center;">6,281,454 Shares<br></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock</div><div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 13.25pt;"> </div></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">This prospectus relates to resales of shares of common stock previously issued by us to the selling stockholders, as identified on page <a href="#tSS">4</a> of this prospectus, in connection with our acquisitions of Novellus, Inc., a Delaware corporation that is the sole equity holder of Novellus Therapeutics Limited. We will not receive any proceeds from the sale of the shares.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The selling stockholders, or their pledgees, donees, transferees or other successors-in-interest, may offer the shares from time to time through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. We will not receive any of the proceeds from the sale of shares of common stock by the selling stockholders. We will bear all costs, expenses and fees in connection with the registration of the common stock. The selling stockholders will bear all commissions and discounts and transfer taxes, if any, attributable to their sale of common stock. For more information, see &#8220;Plan of Distribution&#8221;.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The common stock is listed on the NYSE American under the symbol &#8220;BTX.&#8221; On August&#160;12, 2021, the closing sale price of the common stock as reported on the NYSE American was $11.74. You are urged to obtain current market quotations for the common stock.</div><div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 15.25pt;"> </div></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Investing in these securities involves significant risks. See &#8220;Risk Factors&#8221; included on page <a href="#tRF">2</a> of this prospectus, in any accompanying prospectus supplement and in the documents incorporated by reference in this prospectus for a discussion of the factors you should carefully consider before deciding to purchase these securities.</div><div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 15.25pt;"> </div></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</div><div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 15.25pt;"> </div></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The selling stockholders may sell the shares of common stock offered by this prospectus in a number of different ways and at varying prices, as described in &#8220;Plan of Distribution&#8221; on page <a href="#tPLAN">8</a>.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We have agreed to bear all of the expenses incurred in connection with the registration of the shares of common stock offered by this prospectus. The selling stockholders will pay or assume any discounts, commissions, or fees of underwriters, selling brokers or dealer managers incurred in connection with its sales of the shares.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">As a &#8220;smaller reporting company&#8221; under applicable rules of the Securities and Exchange Commission, we have elected to comply with certain reduced public company disclosure requirements for this prospectus and other filings with the Securities and Exchange Commission. See &#8220;Prospectus Summary&#8212;Implications of Being a Smaller Reporting Company.&#8221;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 50pt; text-align: center;">The date of this prospectus is &#8195;&#8195;&#8195;, 2021.</div></div></div></div>
<!--End Page 2-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 3-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_102-toc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">TABLE OF CONTENTS</div><a name="TOC"><!--Anchor--></a><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.51%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tAB">ABOUT THIS PROSPECTUS<font style="padding-left: 4.33pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tAB"><font style="padding-left: 4.44pt;">ii</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSUM">PROSPECTUS SUMMARY<font style="padding-left: 2.84pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tSUM"><font style="padding-left: 5pt;">1</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF">RISK FACTORS<font style="padding-left: 4.32pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tRF"><font style="padding-left: 5pt;">2</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCN">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS<font style="padding-left: 0.2pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tCN"><font style="padding-left: 5pt;">3</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUSE">USE OF PROCEEDS<font style="padding-left: 0.07pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tUSE"><font style="padding-left: 5pt;">4</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSS">SELLING STOCKHOLDERS<font style="padding-left: 0.82pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tSS"><font style="padding-left: 5pt;">4</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDES">DESCRIPTION OF CAPITAL STOCK<font style="padding-left: 3.11pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tDES"><font style="padding-left: 5pt;">5</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPLAN">PLAN OF DISTRIBUTION<font style="padding-left: 3.98pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tPLAN"><font style="padding-left: 5pt;">8</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">LEGAL MATTERS<font style="padding-left: 3.22pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tLM">10</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tE">EXPERTS<font style="padding-left: 1.77pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tE">10</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWYC">WHERE YOU CAN FIND MORE INFORMATION<font style="padding-left: 3.84pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;"><a href="#tWYC">10</a></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">i<br></div></div></div>
<!--End Page 3-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 4-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_103-about_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tAB"><!--Anchor--></a>ABOUT THIS PROSPECTUS</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC, using a &#8220;shelf&#8221; registration process. Under this shelf registration process, the selling stockholders may, from time to time, offer and sell the shares described in this prospectus in one or more offerings. Before making your investment decision, we urge you to carefully read this prospectus and all of the information contained in the documents incorporated by reference in this prospectus, as well as the additional information described under the headings &#8220;Where You Can Find More Information.&#8221;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In connection with the offer and sale of securities by the selling stockholders, the selling stockholders may provide a prospectus supplement to this prospectus that contains specific information about the securities being offered and sold and the specific terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement or free writing prospectus may also add, update or change information contained in this prospectus with respect to that offering. If there is any inconsistency between the information in this prospectus and any applicable prospectus supplement or free writing prospectus, you should rely on the prospectus supplement or free writing prospectus, as applicable. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">To the extent there is a conflict between the information contained in this prospectus, on the one hand, and the information contained in any document incorporated by reference in this prospectus, on the other hand, you should rely on the information in this prospectus, provided that if any statement in one of these documents is inconsistent with a statement in another document having a later date&#8212;for example, a document incorporated by reference in this prospectus&#8212;the statement in the document having the later date modifies or supersedes the earlier statement.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference in this prospectus were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreement, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We have not, and the selling stockholders have not, authorized anyone to provide you with any information or to make any representations other than that contained in or incorporated by reference in this prospectus, any prospectus supplement or in any related free writing prospectus filed by us with the Securities and Exchange Commission. This prospectus does not constitute an offer to sell or the solicitation of an offer to buy any securities other than the securities described in this prospectus or an offer to sell or the solicitation of an offer to buy such securities in any circumstances in which such offer or solicitation is unlawful. You should assume that the information appearing in this prospectus is accurate only as of the date on its respective cover, that the information appearing in any applicable free writing prospectus is accurate only as of the date of that free writing prospectus, and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial condition, results of operations and prospects may have changed materially since those dates.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">References in this prospectus to &#8220;our company,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;we&#8221; and similar terms refer to Brooklyn ImmunoTherapeutics, Inc. and not, unless the context otherwise requires, subsidiaries of Brooklyn ImmunoTherapeutics, Inc.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Unless the context otherwise requires, this prospectus reflects a one-for-two reverse split of common stock effective as of March&#160;25, 2021.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our logo design is our trademark. This prospectus also includes trademarks, trade names and service marks that are the property of other organizations. For convenience, our logo appears in this prospectus without the &#8482; symbol, but those uses are not intended to indicate that we will not assert, to the fullest extent under applicable law, our rights to this trademark.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">ii<br></div></div></div>
<!--End Page 4-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 5-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="ny20000330x1_s-3_104-sum_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="page-content" style="margin-left: 12pt;"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSUM"><!--Anchor--></a>PROSPECTUS SUMMARY</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: justify;">This summary highlights, and is qualified in its entirety by, the more detailed information included elsewhere or incorporated by reference in this prospectus. This summary does not contain all of the information that may be important to you. You should read and carefully consider the entire prospectus, especially as described in &#8220;Risk Factors,&#8221; before deciding to invest in common stock.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Overview</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We are a clinical-stage biopharmaceutical company focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. We are seeking to develop IRX-2, a novel cytokine-based therapy, to treat patients with cancer. IRX-2 active constituents, namely Interleukin-2 and other key cytokines, are postulated to signal, enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells, unlike existing cancer therapies, which rely on targeting the cancer directly. We also are exploring opportunities to advance oncology, blood disorder, and monogenic disease therapies using gene-editing cell therapy technology through a license with Factor Biosciences Limited and through our acquisition of Novellus, Inc. and its wholly owned subsidiary Novellus Therapeutics Limited.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Corporate Information</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We incorporated under the laws of the State of Delaware in 1984. We changed our name from our initial name Alroy Industries, Inc. to NTN Communications, Inc. in 1985, and then to NTN Buzztime, Inc. in 2005 and to Brooklyn ImmunoTherapeutics, Inc. on March&#160;25, 2021. Our principal executive office is located at 140 58th Street, Suite&#160;2100, Brooklyn, New York 11220, and our telephone number is (212) 582-1199. Our website address is www.brooklynitx.com. The information contained on, or that can be accessed through, our website is not a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Implications of Being a Smaller Reporting Company</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We are a &#8220;smaller reporting company&#8221; because the market value of our stock held by non-affiliates is less than $700&#160;million and our annual revenue was less than $100&#160;million during our most recently completed fiscal year. We may continue to be a smaller reporting company if either (a) the market value of our stock held by non-affiliates is less than $250&#160;million or (b) our annual revenue was less than $100&#160;million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700&#160;million. We may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. For so long as we remain a smaller reporting company, we are permitted and intend to rely on exemptions from certain disclosure and other requirements that are applicable to public companies that are not smaller reporting companies.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">The Offering</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 7pt; margin-left: 0pt; text-align: left;">Common stock offered<font style="font-weight: normal; padding-left: 0.84pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">All of the shares offered by this prospectus are being sold by the selling stockholders. The selling stockholders consist of the former owners or beneficial owners of Novellus, Inc., who acquired their offered shares in connection with our acquisition of Novellus Inc., the parent of Novellus Therapeutics Limited, in July 2021.</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Use of proceeds<font style="font-weight: normal; padding-left: 1.38pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: justify;">We will not receive any proceeds from the sale of shares of common stock offered by this prospectus.</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">NYSE American symbol<font style="font-weight: normal; padding-left: 5.97pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -10pt; margin-left: 240pt; text-align: left;">&#8220;BTX&#8221;</div></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">1<br></div></div></div>
<!--End Page 5-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 6-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_105-risk_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tRF"><!--Anchor--></a>RISK FACTORS</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Investment in common stock offered pursuant to this prospectus and any applicable prospectus supplement involves risks. Before acquiring any such shares of common stock, you should carefully consider the risk factors incorporated by reference to our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K filed by us, and all other information contained or incorporated by reference into this prospectus, as updated by our filings under the Securities Exchange Act of 1934, or the Exchange Act, and the risk factors and other information contained in the applicable prospectus supplement and any applicable free writing prospectus. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">2<br></div></div></div>
<!--End Page 6-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 7-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_106-caution_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCN"><!--Anchor--></a>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">This prospectus and the information incorporated by reference in this prospectus include &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, or the Securities Act, and Section 21E of the Exchange Act. These statements are based on expectations, estimates, forecasts and projections about the industry in which we operate and the beliefs and assumptions of management. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;goals,&#8221; &#8220;seek,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;hypothesize,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;continue&#8221; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements in this prospectus and the information incorporated by reference in this prospectus include statements about:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our plans to develop and commercialize IRX-2 and other product candidates, including the potential benefits thereof;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our ongoing and future clinical trials for IRX-2, whether conducted by us or by any future collaborators, including the timing of initiation of these trials and of the anticipated results;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our plans to advance oncology, blood disorder, and monogenic disease therapies through gene-editing cell therapy technology;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our expectations regarding our ability to fund our operating expenses and capital expenditure requirements with our cash, cash equivalents and investments;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the timing of and our ability to obtain and maintain marketing approvals for our product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the rate and degree of market acceptance and clinical utility of any products for which we receive marketing approval;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our commercialization, marketing and manufacturing capabilities and strategy;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our intellectual property position and strategy;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to identify additional product candidates with significant commercial potential;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our plans to enter into collaborations for the development and commercialization of product candidates;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">potential benefits of any future collaboration;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">developments relating to our competitors and our industry;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the impact of government laws and regulations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the impact the coronavirus pandemic will have on the timing of our clinical development and operations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to continue as a going concern;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to maintain our listing on the NYSE American.</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in our forward-looking statements. We have included important factors in the cautionary statements included, or incorporated by reference, in this prospectus, particularly in &#8220;Risk Factors,&#8221; that we believe could cause actual results or events to differ materially from our forward-looking statements. You should also carefully review the risk factors and cautionary statements described in the other documents we file from time to time with the SEC that are incorporated in this prospectus by reference, specifically our most recent Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and our Current Reports on Form&#160;8-K. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, collaborations, joint ventures or investments to which we may be a party.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">You should read this prospectus, the documents incorporated by reference in this prospectus and the documents that we have filed as exhibits to the registration statement of which this prospectus forms a part completely and with the understanding that our actual future results may be materially different from what we expect. The forward-looking statements contained in this prospectus and incorporated by reference in this prospectus are made as of the respective dates thereof, and we do not assume any obligation to update any forward-looking statements except as required by applicable law.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">3<br></div></div></div>
<!--End Page 7-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 8-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_107-use_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tUSE"><!--Anchor--></a>USE OF PROCEEDS</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">All of the shares of common stock offered by this prospectus are being offered by the selling stockholders. For information about the selling stockholders, see &#8220;Selling Stockholders.&#8221; We will not receive any proceeds from the sale of shares by the selling stockholders.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The selling stockholders will pay any underwriting discounts and commissions and expenses incurred by the selling stockholders for brokerage, accounting, tax or legal services or any other expenses incurred by the selling stockholders in disposing of the offered shares. We will bear all other costs, fees and expenses incurred in effecting the registration of the shares covered by this prospectus, including all registration and filing fees and fees and expenses of our counsel and our accountants.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tSS"><!--Anchor--></a>SELLING STOCKHOLDERS</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We issued the shares of common stock covered by this prospectus to the former owners or beneficial owners of Novellus, Inc., in connection with our acquisition of Novellus Inc., the parent of Novellus Therapeutics Limited in July 2021. We are filing the registration statement of which this prospectus forms a part pursuant to the provisions of the registration rights agreement we entered into with the selling stockholders on July&#160;16, 2021. The selling stockholders may, from time to time, offer and sell pursuant to this prospectus up to 6,281,454 shares of common stock that we issued to the selling stockholders in connection with our acquisition of Novellus, Inc. The selling stockholders may sell some, all or none of the shares of common stock acquired in connection with the acquisition. We cannot estimate or predict how long the selling stockholders will hold shares of common stock before selling them, and we have no agreements, arrangements or understandings with the selling stockholders regarding the sale of any of the shares. See &#8220;Plan of Distribution.&#8221;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to shares of common stock. The percentages of shares of common stock owned are based on 51,729,612&#160;shares of common stock outstanding as of August&#160;12, 2021. The information in the table below with respect to the selling stockholder has been obtained from the selling stockholder. Unless otherwise indicated below, the address of each beneficial owner listed in the table below is c/o Brooklyn ImmunoTherapeutics, Inc., 140&#160;58th&#160;Street, Suite 2100, Brooklyn, New York 11220.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We may amend or supplement this prospectus from time to time in the future to update or change this selling stockholders list and the securities that may be resold.</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 18.76%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares Beneficially <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Owned <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Before Offering</div></td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 12.97%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares to be Sold <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pursuant to <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Offering</div></td><td class="gutter" rowspan="2" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.71%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares Beneficially Owned <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">After Offering</div></td></tr><tr class="header"><td style="width: 41.03%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name of Selling Stockholder</div></td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number </div></td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Percentage</div></td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.28%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number </div></td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.09%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Percentage</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">JPG Investments, LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 2.73pt;"></font></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">250,000</font></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.55pt; text-align: left;"><font style="padding-left: 12.5pt;">*</font></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 12.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.36pt; text-align: left;"><font style="padding-left: 7.5pt;">250,000</font></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.28%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.39pt; text-align: left;">&#8212;</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.98pt; text-align: left;">&#8212;%</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leonard Mazur<font style="padding-left: 1.75pt;"></font></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">1,815,362 </div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.55pt; text-align: left;">3.5%</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.36pt; text-align: left;">1,815,362</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.28%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.39pt; text-align: left;">&#8212; </div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.98pt; text-align: left;">&#8212;</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Novellus LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)(3)</sup><font style="padding-left: 3.69pt;"></font></div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">4,216,092 </div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.55pt; text-align: left;">8.2</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 12.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.36pt; text-align: left;">4,216,092</div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.28%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.39pt; text-align: left;">&#8212; </div></td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.98pt; text-align: left;">&#8212;</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Less than 1%</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Robert E. Grant, Richard E. Grant and Michael J. Grant may be deemed beneficial owners of the shares of common stock owned by JPG Investments, LLC. Messers Grant have shared voting and investment power over the shares being offered under this prospectus. Messers.&#160;Grant each disclaim beneficial ownership except to the extent of each of their pecuniary interest therein.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Matthew Angel and Christopher Rohde may be deemed to be beneficial owners of all of the shares of common stock owned by Novellus LLC. Messrs. Angel and Rohde have shared voting and investment power over the shares being offered under this prospectus.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Shares of common stock owned by Novellus LLC include (a) 2,392,403 shares intended for distribution Factor Bioscience, Inc., (b)&#160;556,803&#160;shares intended for distribution to Matthew Angel and (c) 803,785 shares intended for distribution to Christophe Rohde. Factor Biosciences, Inc. and Messers. Angel and Rohde have entered into lock-up agreements with respect to 3,377,690 shares of common stock covered by this prospectus. Each lock-up agreement extends for a period of three years, provided that up to 75% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock on the NYSE American stock exchange exceeds specified thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">4<br></div></div></div>
<!--End Page 8-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 9-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_108-description_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDES"><!--Anchor--></a>DESCRIPTION OF CAPITAL STOCK</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">General</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The following description of our capital stock is intended as a summary only and therefore is not complete. This description is based upon, and is qualified by reference to, our certificate of incorporation and bylaws, each as amended from time to time, and by applicable provisions of the Delaware General Corporation Law. You should read our certificate of incorporation and bylaws, which are filed as exhibits to the registration statement of which this prospectus forms a part, for the provisions that are important to you.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our authorized capital stock consists of 100,000,000 shares of common stock, par value $0.005 per share, and 1,000,000 shares of preferred stock, par value $0.005 per share. A total of 156,112 shares of preferred stock have been designated as Series A convertible preferred stock. The following description of our capital stock and provisions of our certificate of incorporation and bylaws are summaries and are qualified by reference to our certificate of incorporation and bylaws. As of August&#160;12, 2021, 51,729,612 shares of common stock were outstanding and 156,112 shares of Series A convertible preferred stock were outstanding. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Common Stock</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Voting Rights<font style="font-style: normal;">. Each holder of common stock is entitled to one vote for each share on all matters submitted to a vote </font><font style="font-style: normal;">of the stockholders, including the election of directors. Votes may be cast in person or by proxy. Stockholders do not </font><font style="font-style: normal;">have cumulative voting rights with respect to election of directors.</font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Dividends<font style="font-style: normal;">. Holders of common stock are entitled to receive proportionately any dividends as may be declared and </font><font style="font-style: normal;">paid on common stock from funds lawfully available therefor as and when determined by the board of directors, </font><font style="font-style: normal;">subject to any preferential dividend rights of outstanding preferred stock.</font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Liquidation and Dissolution<font style="font-style: normal;">. In the event of our liquidation or dissolution, the holders of common stock are entitled </font><font style="font-style: normal;">to receive proportionately all assets available for distribution to stockholders after the payment of all debts and other </font><font style="font-style: normal;">liabilities and subject to the prior rights of any outstanding preferred stock.</font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Other Rights<font style="font-style: normal;">. Holders of common stock have no preemptive, subscription, redemption or conversion rights. The </font><font style="font-style: normal;">rights, preferences and privileges of holders of common stock are subject to and may be adversely affected by the </font><font style="font-style: normal;">rights of the holders of shares of any series of preferred stock. Outstanding shares of common stock are </font><font style="font-style: normal;">non-assessable. Holders of common stock are not, and will not be, subject to any liability as stockholders.</font></div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Series A Convertible Preferred Stock</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Voting Rights<font style="font-style: normal;">. Series A convertible preferred stock has no voting rights.</font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Dividends<font style="font-style: normal;">. The holders of Series A convertible preferred stock are entitled to receive cumulative dividends of $0.10 </font><font style="font-style: normal;">per share per annum, payable semiannually in equal installments of $0.05 per share on June 1 and December 1 of </font><font style="font-style: normal;">each year.</font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Liquidation and Dissolution<font style="font-style: normal;">. Upon liquidation, dissolution and winding up, each share of Series A convertible </font><font style="font-style: normal;">preferred stock will have preference over common stock to the extent of $1.00 per share, but will not otherwise be </font><font style="font-style: normal;">entitled to share in the proceeds of any liquidation, dissolution or winding up. The preference or subordination of the </font><font style="font-style: normal;">rights of Series A convertible preferred stock with respect to any other class of stock, or any other series of preferred </font><font style="font-style: normal;">stock, shall be as stated in the instrument defining the rights of such other class or series.</font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Conversion Rights<font style="font-style: normal;">. Shares of Series A convertible preferred stock are convertible at any time at the option of the </font><font style="font-style: normal;">holder into a number of duly authorized, validly issued, fully paid and nonassessable shares of common stock equal </font><font style="font-style: normal;">to the number of shares of Series A convertible preferred stock surrendered for conversion divided by the conversion </font><font style="font-style: normal;">rate, which is approximately 3.7033 as of August&#160;12, 2021 and which is subject to certain adjustments. No fractional </font><font style="font-style: normal;">shares shall be issued upon conversion of Series A convertible preferred stock, and any portion of a share of Series </font><font style="font-style: normal;">A convertible preferred stock that would otherwise be convertible into a fractional share shall be paid in cash in the </font><font style="font-style: normal;">amount of the liquidation preference of the fractional share. No payment or adjustment shall be made upon any </font><font style="font-style: normal;">conversion on account of any cash dividends on the common stock issued upon such conversion.</font></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">5<br></div></div></div>
<!--End Page 9-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 10-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_108-description_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Provisions of Our Certificate of Incorporation and Bylaws and Delaware General Corporation Law may have Anti-Takeover Effects</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our certificate of incorporation and bylaws and the Delaware General Corporation Law contain provisions that could have the effect of delaying, deferring or discouraging another party from acquiring control of us. These provisions, which are summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids and are designed in part to encourage persons seeking to acquire control of us to first negotiate with the board of directors.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Number of Directors; Vacancies</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our certificate of incorporation provides that the number of directors is established by the board of directors, which may delay the ability of stockholders to change the composition of a majority of the board. The board has the exclusive right to elect a director to fill any vacancy or newly created directorship.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Removal of Directors</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">A director may be removed only by the affirmative vote of the holders of at least 80% of the voting power of all shares entitled to vote generally in the election of directors, voting together as a single class.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Stockholder Action by Written Consent; Special Meetings</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our certificate of incorporation provides that any action required or permitted to be taken by our stockholders must be effected at a duly called annual or special meeting of such holders and may not be effected by any consent in writing by such holders. Our certificate of incorporation and bylaws also provide that, except as otherwise required by law, special meetings of our stockholders can only be called by the board of directors. These provisions may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Advance Notice Requirements for Stockholder Proposals</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our bylaws establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of stockholders, including proposed nominations of persons for election to the board of directors. Stockholders at an annual meeting may consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the board or by a stockholder of record on the record date for the meeting who is entitled to vote at the meeting and who has delivered timely written notice in proper form to our secretary of the stockholder&#8217;s intention to bring such business before the meeting. These provisions could have the effect of delaying until the next stockholder meeting stockholder actions that are favored by the holders of a majority of our outstanding voting securities.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Delaware Business Combination Statute</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We are subject to Section 203 of the Delaware General Corporation Law. Subject to certain exceptions, Section 203 prevents a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with any &#8220;interested stockholder&#8221; for three years following the date that the person became an interested stockholder, unless the interested stockholder attained such status with the approval of the board of directors or unless the business combination is approved in a prescribed manner. A &#8220;business combination&#8221; includes, among other things, a merger or consolidation involving us and the &#8220;interested stockholder&#8221; and the sale of more than 10% of our assets. In general, an &#8220;interested stockholder&#8221; is any entity or person beneficially owning 15% or more of our outstanding voting stock and any entity or person affiliated with or controlling or controlled by such entity or person.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Certificate of Incorporation or Bylaws</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Any provision of our certificate of incorporation may be amended, altered, changed or repealed in any manner prescribed by law, provided that (a) the affirmative vote of the holders of at least 80% of the voting power of all shares entitled to vote generally in the election of directors, voting together as a single class, is required to alter, amend, or repeal, or adopt any provision inconsistent with Article X of the certificate of incorporation, which contains the prohibition on stockholder action by written consent and the requirement that special meetings be called only by the board of directors, and (b) Article XI of the certificate of incorporation, which provides that, subject to certain exceptions, no purchase by or from any Controlling Person (as defined below) of shares of our stock owned by such</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">6<br></div></div></div>
<!--End Page 10-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 11-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_108-description_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Controlling Person shall be made at a price exceeding the average price paid by such Controlling Person for all shares of our stock acquired by such Controlling Person during the two-year period preceding the date of such proposed purchase unless such purchase is approved by the affirmative vote of not less than a majority of the voting power of the shares of our stock entitled to vote held by Disinterested Stockholders (as defined below), may not be amended without the affirmative vote of not less than a majority of the our stock entitled to vote thereon, provided that if, at the time of such vote, there shall be one or more Controlling Persons, such affirmative vote shall include the affirmative vote in favor of such amendment of not less than a majority of the voting power of the shares of our stock entitled to vote thereon held by Disinterested Stockholders. &#8220;Controlling Person&#8221; means any individual, corporation, partnership, trust, association or other organization or entity (including any group formed for the purpose of acquiring, voting or holding our securities) which either directly, or indirectly through one or more intermediaries, owns, beneficially or of record, or controls by agreement, voting trust or otherwise, at least 10% of the voting power of stock, and such term also includes any corporation, partnership, trust, association or other organization or entity in which one or more Controlling Persons have the power, through the ownership of voting securities, by contract, or otherwise, to influence significantly any of the management, activities or policies of such corporation, partnership, trust, association, other organization or entity. &#8220;Disinterested Stockholders&#8221; means those holders of stock entitled to vote on any matter, none of which is a Controlling Person.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">The board may, by majority vote, amend or repeal our bylaws and may adopt new bylaws.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our stockholders may not adopt, amend, or repeal our bylaws or adopt new bylaws except by the vote or written consent of at least 66-2/3% of the voting power of our company.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 18pt; margin-left: 0pt; text-align: left;">Exclusive Forum Selection</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or if the Court of Chancery does not have jurisdiction, the federal district court for the District of Delaware) shall be the sole and exclusive forum for (a) any derivative action or proceeding brought on our behalf, (b) any action asserting a claim of breach of a fiduciary duty owed by any of our directors or officers to our company or stockholders, (c) any action asserting a claim against us arising pursuant to any provision of the Delaware General Corporation Law or our certificate of incorporation or amended and restated bylaws, or (d) any action asserting a claim against us governed by the internal affairs doctrine. We do not expect this choice of forum provision will apply to suits brought to enforce a duty or liability created by the Securities Act, the Exchange Act or any other claim for which federal courts have exclusive jurisdiction. Although our bylaws contain the choice of forum provision described above, it is possible that a court could rule that such a provision is inapplicable for a particular claim or action or that such provision is unenforceable.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Authorized but Unissued Shares</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our authorized but unissued shares of common stock and preferred stock are available for future issuance without stockholder approval, subject to any limitations imposed by the listing requirements of the NYSE American. These additional shares may be used for a variety of corporate finance transactions, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could make it more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Stock Options and Restricted Stock Units</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">As of August&#160;12, 2021, we had outstanding options to purchase 3,436,748 shares of common stock at a weighted average price $8.54 per share and 140,990 outstanding restricted stock units with a weighted average intrinsic value of $17.25 per share.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Listing on the NYSE American</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;">The common stock is listed on the NYSE American under the symbol &#8220;BTX.&#8221;</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Transfer Agent and Registrar</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;">The transfer agent and registrar for the common stock is American Stock Transfer &amp; Trust Company, LLC.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">7<br></div></div></div>
<!--End Page 11-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 12-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_109-plan_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPLAN"><!--Anchor--></a>PLAN OF DISTRIBUTION</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The shares covered by this prospectus may be offered and sold from time to time by the selling stockholders. The selling stockholders, which as used herein includes their transferees, pledgees, donees, assignees or other successors-in-interest, may, from time to time, sell, transfer or otherwise dispose of any or all of their common stock on the NYSE American or any other stock exchange, market or trading facility on which such common stock is traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale or at negotiated prices.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The selling stockholders will act independently of us in making decisions with respect to the timing, manner and size of each sale. The selling stockholders may sell their shares of common stock by one or more of, or a combination of, the following methods:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">block trades in which the broker-dealer will attempt to sell common stock as agent, but may position and resell a portion of the block as principal to facilitate the transaction;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an exchange distribution in accordance with the rules of the applicable exchange;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">privately negotiated transactions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">in underwriting transactions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">short sales;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">broker-dealers may agree with the selling stockholders to sell a specified number of shares of common stock at a stipulated price;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">distribution to employees, members, limited partners or stockholders of selling stockholders;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a combination of any such methods of sale;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;at the market&#8221; or through market makers or into an existing market for the shares; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any other method permitted pursuant to applicable law.</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In addition, any shares that qualify for sale pursuant to Rule 144 may be sold under Rule 144 rather than pursuant to this prospectus.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">To the extent required, this prospectus may be amended or supplemented from time to time to describe a specific plan of distribution. In connection with distributions of common stock or otherwise, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short sales of the securities in the course of hedging the positions they assume with selling stockholders. The selling stockholders may also sell common stock short and redeliver the securities to close out such short positions. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions which require the delivery to such broker-dealer or other financial institution of the common stock offered by this prospectus, which common stock such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). The selling stockholders may also pledge common stock to a broker-dealer or other financial institution, and, upon a default, such broker-dealer or other financial institution, may effect sales of the pledged shares of common stock pursuant to this prospectus (as supplemented or amended to reflect such transaction).</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">A selling stockholder may enter into derivative transactions with third parties, or sell common stock not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell shares of common stock covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use shares of common stock pledged by any selling stockholder or borrowed from any selling stockholder or others to settle those sales or to close out any related open borrowings of stock, and may use common stock received from any selling stockholder in settlement of those derivatives to close out any related open borrowings of stock. The third party in </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">8<br></div></div></div>
<!--End Page 12-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 13-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_109-plan_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">such sale transactions will be an underwriter and will be identified in the applicable prospectus supplement (or a post-effective amendment). In addition, any selling stockholder may otherwise loan or pledge shares of common stock to a financial institution or other third party that in turn may sell the common stock short using this prospectus. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In effecting sales, broker-dealers or agents engaged by the selling stockholders may arrange for other broker-dealers to participate. Broker-dealers or agents may receive commissions, discounts or concessions from the selling stockholders in amounts to be negotiated immediately prior to the sale.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In offering the shares of common stock covered by this prospectus, the selling stockholders and any broker-dealers who execute sales for the selling stockholders may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with such sales. Any profits realized by the selling stockholders and the compensation of any broker-dealer may be deemed to be underwriting discounts and commissions.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Certain of the selling stockholders, or their beneficial owners, have entered into lock-up agreements with respect to 3,377,690 shares of common stock covered by this prospectus. Each lock-up agreement extends for a period of three years, provided that up to 75% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock on the NYSE American stock exchange exceeds specified thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In order to comply with the securities laws of certain states, if applicable, the shares of common stock covered by this prospectus must be sold in such jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states the securities may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We have advised the selling stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of securities in the market and to the activities of the selling stockholders and their affiliates. In addition, we will make copies of this prospectus available to the selling stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates in transactions involving the sale of the securities against certain liabilities, including liabilities arising under the Securities Act.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">At the time a particular offer of shares of common stock is made, if required, a prospectus supplement will be distributed that will set forth the number of securities being offered and the terms of the offering, including the name of any underwriter, dealer or agent, the purchase price paid by any underwriter, any discount, commission and other item constituting compensation, any discount, commission or concession allowed or reallowed or paid to any dealer, and the proposed selling price to the public.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We have agreed to indemnify the selling stockholders against certain liabilities, including certain liabilities under the Securities Act, the Exchange Act or other federal or state law.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We have agreed with the selling stockholders pursuant to our registration rights agreement dated July&#160;16, 2021 to use our commercially reasonable efforts to keep the registration statement of which this prospectus constitutes a part effective until such time as: (i)&#160;all shares of common stock covered by this prospectus have been sold, transferred, disposed of or exchanged in accordance with the registration statement; (ii)&#160;such shares of common stock shall have been otherwise transferred, new certificates for such securities not bearing (or book entry positions not subject to) a legend restricting further transfer shall have been delivered by us and subsequent public distribution of such securities shall not require registration under the Securities Act; (iii)&#160;such shares of common stock have ceased to be outstanding; (iv)&#160;such shares of common stock have been sold to, or through, a broker, dealer, or underwriter in a public distribution or other public securities transaction; or (v)&#160;such shares are eligible to be resold pursuant to Rule&#160;144 under the Securities Act without volume limitation.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">9<br></div></div></div>
<!--End Page 13-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 14-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_109-plan_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tLM"><!--Anchor--></a>LEGAL MATTERS</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The validity of the shares of common stock offered hereby is being passed upon for us by K&amp;L Gates LLP, Boston, Massachusetts.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; text-align: center;"><a name="tE"><!--Anchor--></a>EXPERTS</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The consolidated financial statements of NTN Buzztime, Inc. (now known as Brooklyn ImmunoTherapeutics, Inc.) as of December&#160;31, 2020 and 2019 and for each of the years in the two-year period ended December&#160;31, 2020 have been audited by Baker Tilly US, LLP, an independent registered public accounting firm, as stated in their report thereon (which report expresses an unqualified opinion and includes an explanatory paragraph relating to NTN Buzztime, Inc.&#8217;s ability to continue as a going concern), incorporated herein by reference, and have been incorporated in this Prospectus and Registration Statement in reliance upon such report and upon the authority of such firm as experts in accounting and auditing.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The financial statements of Brooklyn ImmunoTherapeutics LLC (and its predecessor IRX Therapeutics, Inc.) for the years ended December&#160;31, 2020 and 2019 incorporated in this prospectus by reference to our Amendment No. 1 on Form 8-K/A dated April&#160;30, 2021 have been so incorporated in reliance on the report of Marcum LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; text-align: center;"><a name="tWYC"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Available Information</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We file reports, proxy statements and other information with the Securities and Exchange Commission, or SEC. Information we filed with the SEC can be inspected and copied at the Public Reference Room maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549. You may also obtain copies of this information by mail from the Public Reference Room of the SEC at prescribed rates. Further information on the operation of the SEC&#8217;s Public Reference Room in Washington, D.C. can be obtained by calling the SEC at 1-800-SEC-0330. The SEC also maintains a website at <font style="font-style: italic;">www.sec.gov</font> that contains reports, proxy and information statements and other information about issuers, such as us, who file electronically with the SEC. Copies of certain information we have filed with the SEC are also available on our website at <font style="font-style: italic;">www.brooklynitx.com</font>, but our website is not a part of this prospectus and the information on our website is not incorporated by reference in, or otherwise part of, this prospectus.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">This prospectus is part of a registration statement we filed with the SEC and does not contain all of the information contained in the registration statement. The full registration statement may be obtained from the SEC or us, as provided below. You should review the information and exhibits in the registration statement for further information about us and our consolidated subsidiary and the securities we are offering. Statements in this prospectus concerning any document that we filed as an exhibit to the registration statement or that we otherwise filed with the SEC are summaries and each statement is qualified in all respects by reference to the document to which it refers. You should review the complete document to evaluate these statements. You may inspect a copy of the registration statement at the SEC&#8217;s Public Reference Room in Washington, D.C. or through the SEC&#8217;s website, as provided above.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Incorporation by Reference</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The SEC&#8217;s rules allow us to &#8220;incorporate by reference&#8221; information into this prospectus, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede that information. Any statement contained in this prospectus or a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or a subsequently filed document incorporated by reference modifies or replaces that statement.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">This prospectus incorporates by reference the documents listed below (File No. 001-11460) and any future filings we make with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act of 1934 between the date of this prospectus and the termination of the offering of the shares offered by this prospectus, other than the portions of those documents not deemed to be filed:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/748592/000149315221005827/form10-k.htm">March&#160;11, 2021</a>; </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">10<br></div></div></div>
<!--End Page 14-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 15-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_109-plan_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2021 filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121017648/brhc10024479_10q.htm">May&#160;17, 2021</a>;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our Current Reports on Form 8-K filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/748592/000149315221001197/form8-k.htm">January&#160;15, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000149315221002556/form8-k.htm">February&#160;4, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000149315221003076/form8-k.htm">February&#160;9, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000149315221004770/form8-k.htm">February&#160;25, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000149315221004937/form8-k.htm">February&#160;26, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000149315221005525/form8-k.htm">March&#160;8, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000149315221006033/form8-k.htm">March&#160;16, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000149315221006655/form8-k.htm">March&#160;23, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121015352/brhc10023628_8ka.htm">March&#160;31, 2021</a> (as amended by Amendment No. 1 on Form 8-K/A filed on April&#160;30, 2021), <a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121012036/brhc10022864_8k.htm">April&#160;7, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121012968/brhc10022998_8k.htm">April&#160;15, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121013151/brhc10023212_8k.htm">April&#160;16, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121014148/brhc10023524_8k.htm">April&#160;23, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121015275/nt10023650x2_8k.htm">April&#160;30, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121016863/brhc10024430_8k.htm">May&#160;11, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121018871/brhc10025183_8k.htm">May&#160;26, 2021</a>, <a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121020543/brhc10025686_8k.htm">June&#160;10, 2021</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/748592/000114036121021741/brhc10026052_8k.htm">June&#160;21, 2021</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/748592/000114036121024732/brhc10026994_form8k.htm">July&#160;19, 2021</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/748592/000114036121024792/brhc10027031_8k.htm">July&#160;19, 2021</a>; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the description of common stock contained in Exhibit 4.2 to our Annual Report on Form 10-K for the year ended December&#160;31, 2019 filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/748592/000149315220004343/ex4-2.htm">March&#160;19, 2020</a>, including any amendments or reports filed for the purpose of updating such description.</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">A statement contained in a document incorporated by reference into this prospectus shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus, any prospectus supplement or in any other subsequently filed document that is incorporated in this prospectus modifies or replaces such statement. Any statements so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">You may request a copy of these filings, at no cost, by writing or calling us at Brooklyn ImmunoTherapeutics, Inc., 140 58th Street, Suite 2100, Brooklyn, New York 11220, telephone (212) 582-1199.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">11<br></div></div></div>
<!--End Page 15-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 16-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 456pt;"><a name="ny20000330x1_s-3_300-bcv_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="block-frill" style="width: 456pt; margin-left: 0pt;"><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="page-content"><div class="block-main" style="width: 456pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 18.75pt; text-align: center;"><img style="height: 119px; width: 468px;" src="logo_brooklynx1.jpg"><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 176.5pt; text-align: center;">6,281,454 Shares</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 30.5pt; text-align: center;">Common Stock</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 30.5pt; text-align: center;">PROSPECTUS</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 264.5pt; text-align: center;">&#8195;&#8195;&#8195;&#8195;, 2021</div></div></div><div class="block-frill" style="width: 456pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 16-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 17-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_301-part2_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">PART II</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; text-align: center;">INFORMATION NOT REQUIRED IN PROSPECTUS</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 45pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 14.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Other Expenses of Issuance and Distribution.</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The following table sets forth the various expenses to be incurred in connection with the sale and distribution of the securities being registered hereby, all of which will be borne by the Registrant (except any underwriting discounts and commissions and expenses incurred by the selling stockholders for brokerage, accounting, tax or legal services or any other expenses incurred by the selling stockholders in disposing of the shares). All amounts shown are estimates except the Securities and Exchange Commission registration fee.</div><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr><td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">SEC registration fee<font style="padding-left: 2.76pt;"></font></div></td><td class="gutter" style="width: 2.94%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.94%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5.37pt;">&#8203;</font>8,011</div></td></tr><tr><td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accounting fees and expenses<font style="padding-left: 2.22pt;"></font></div></td><td class="gutter" style="width: 2.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5.37pt;">11,000</font></div></td></tr><tr><td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Legal fees and expenses<font style="padding-left: 1.11pt;"></font></div></td><td class="gutter" style="width: 2.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">15,000</font></div></td></tr><tr><td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Miscellaneous fees and expenses<font style="padding-left: 1.13pt;"></font></div></td><td class="gutter" style="width: 2.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">10,989</font></div></td></tr><tr><td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total expenses<font style="padding-left: 0.67pt;"></font></div></td><td class="gutter" style="width: 2.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">45,000</font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 45pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 15.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Indemnification of Directors and Officers.</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Section 102 of the Delaware General Corporation Law permits a corporation to eliminate the personal liability of its directors for monetary damages for a breach of fiduciary duty as a director, except where the director breached his or her duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of the Delaware General Corporation Law or obtained an improper personal benefit. Our certificate of incorporation provides that none of our directors shall be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing such liability, except for liability (a) for any breach of the director&#8217;s duty of loyalty to the corporation or its stockholders, (b) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (c) under section 174 of the Delaware General Corporation Law, or (d) for any transaction from which the director derived an improper personal benefit.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Section 145 of the Delaware General Corporation Law provides that a corporation has the power to indemnify a director, officer, employee, or agent of the corporation and certain other persons serving at the request of the corporation in related capacities against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlements actually and reasonably incurred by the person in connection with an action, suit or proceeding to which he or she is or is threatened to be made a party by reason of such position, if such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our certificate of incorporation provides that we will indemnify, in the manner and to the full extent permitted by law, any person (or the estate of any person) who was or is a party, or is threatened to be made a party to, any threatened, pending or completed action, suit or proceeding, and whether civil, criminal, administrative, investigative or otherwise, by reason of the fact that such person is or was our director, officer, employee or agent, or is or was serving at our request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise. Where required by law, the indemnification provided for shall be made only as authorized in the specific case upon a determination in the manner provided by law, that indemnification of the director, officer, employee or agent is proper under the circumstances. We may, to the full extent permitted by law, purchase and maintain insurance on behalf of any such person against any liability which may be asserted against him. To the full extent permitted by law, the indemnification provided shall include expenses (including attorneys&#8217; fees) in any action, suit or proceeding, or in connection with any appeal therein, judgments, fines and amounts paid in settlement, and in the manner provided by law any such expenses may be paid by us in advance of the final disposition of such action, suit or proceeding. The indemnification described herein does not limit our right to indemnify any other person for </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-1<br></div></div></div>
<!--End Page 17-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 18-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_301-part2_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">any such expense to the full extent permitted by law, nor is it exclusive of any other rights to which any person seeking indemnification from us may be entitled under any agreement, vote of stockholders or disinterested directors or otherwise, both as to action in his or her official capacity and as to action in another capacity while holding such office.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The board of directors has approved a form of indemnification agreement that has been executed by each of our directors and executive officers. In general, these agreements each provide that we will indemnify the director or executive officer to the fullest extent permitted by law for claims arising in his or her capacity as a director or executive officer of our company or in connection with their service at our request for another corporation or entity. The indemnification agreements also provide for procedures that will apply in the event that a director or executive officer makes a claim for indemnification and establish certain presumptions that are favorable to the director or executive officer.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We maintain a general liability insurance policy that covers certain liabilities of our directors and officers arising out of claims based on acts or omissions in their capacities as directors or officers.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 45pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 16.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Exhibits.</div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 10.26%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">EXHIBIT <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">NO.</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 88.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">DESCRIPTION</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000149315221001359/forms-4a.htm#aa_001">2.1+</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Agreement and Plan of Merger and Reorganization, dated August&#160;12, 2020, among Brooklyn ImmunoTherapeutics, Inc. (formerly NTN Buzztime, Inc.), BIT Merger Sub, Inc. and Brooklyn ImmunoTherapeutics LLC (incorporated herein by reference to Exhibit 2.1 to the Registration Statement on Form S-4/A filed on January&#160;20, 2021)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000149315220015948/ex10-1.htm">2.2</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of Support Agreement among Brooklyn ImmunoTherapeutics, Inc. (formerly NTN Buzztime, Inc.), Brooklyn ImmunoTherapeutics LLC and the officers and directors of NTN Buzztime, Inc. (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on August&#160;14, 2020)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000149315220015948/ex10-2.htm">2.3</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of Support Agreement among Brooklyn ImmunoTherapeutics, Inc. (formerly NTN Buzztime, Inc.), Brooklyn ImmunoTherapeutics LLC and certain beneficial holders of Class&#160;A membership interests of Brooklyn ImmunoTherapeutics LLC (incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on August&#160;14, 2020)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000101968713003135/ntn_10q-ex0301.htm">3.1</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restated Certificate of Incorporation of Brooklyn ImmunoTherapeutics, Inc. (formerly NTN Buzztime, Inc.) (incorporated herein by reference to Exhibit 3.1 to the Quarterly Report on Form 10-Q filed on August&#160;14, 2013)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000149315216010919/ex3-1.htm">3.1(a)</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certificate of Amendment to the Restated Certificate of Incorporation of Brooklyn ImmunoTherapeutics, Inc. (formerly NTN Buzztime, Inc.), dated June&#160;16, 2016 (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on June&#160;17, 2016)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000149315217003784/ex3-1.htm">3.1(b)</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certificate of Decrease of the Series A convertible preferred stock of Brooklyn ImmunoTherapeutics, Inc. (formerly NTN Buzztime, Inc.), dated April&#160;10, 2017 (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on April&#160;12, 2017)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000149315217006434/ex3-1.htm">3.1(c)</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certificate of Amendment of Restated Certificate of Incorporation of Brooklyn ImmunoTherapeutics, Inc. (formerly NTN Buzztime, Inc.), dated June&#160;8, 2017 (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on June&#160;9, 2017)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121011095/brhc10022537_ex3-1.htm">3.1(d)</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certificate of Amendment of Restated Certificate of Incorporation of Brooklyn ImmunoTherapeutics, Inc. (formerly NTN Buzztime, Inc.), dated March&#160;25, 2021 (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on March&#160;31, 2021) </div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121011095/brhc10022537_ex3-2.htm">3.1(e)</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certificate of Amendment of Restated Certificate of Incorporation of Brooklyn ImmunoTherapeutics, Inc. (formerly NTN Buzztime, Inc.), dated March&#160;25, 2021 (incorporated herein by reference to Exhibit 3.2 to the Current Report on Form 8-K filed on March&#160;31, 2021)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121011095/brhc10022537_ex3-3.htm">3.1(f)</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certificate of Amendment of Restated Certificate of Incorporation of Brooklyn ImmunoTherapeutics, Inc. (formerly NTN Buzztime, Inc.), dated March&#160;25, 2021 (incorporated herein by reference to Exhibit 3.3 to the Current Report on Form 8-K filed on March&#160;31, 2021)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121011095/brhc10022537_ex3-4.htm">3.2</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amended and Restated Bylaws of Brooklyn ImmunoTherapeutics, Inc. (incorporated herein by reference to Exhibit 3.4 to the Current Report on Form 8-K filed on March&#160;31, 2021)</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-2<br></div></div></div>
<!--End Page 18-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 19-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_301-part2_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 10.26%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">EXHIBIT <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">NO.</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 88.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">DESCRIPTION</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121015372/nt10023650x1_ex4-1.htm">4.1</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Specimen stock certificate evidencing shares of common stock of Brooklyn ImmunoTherapeutics, Inc. (incorporated herein by reference to Exhibit 4.1 to the Registration Statement on Form S-1 filed on April&#160;30, 2021)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121015372/nt10023650x1_ex4-2.htm">4.2</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Description of registrant&#8217;s securities (incorporated herein by reference to Exhibit 4.2 to the Registration Statement on Form S-1 filed on April&#160;30, 2021)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">5.1*</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Opinion of K&amp;L Gates LLP</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/748592/000114036121015372/nt10023650x1_ex21-1.htm">21.1</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Subsidiaries of Brooklyn ImmunoTherapeutics, Inc. (incorporated herein by reference to Exhibit 21.1 to Registration Statement on Form S-1 filed on April&#160;30, 2021)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20000330x1_ex23-1.htm">23.1</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Baker Tilly US, LLP</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20000330x1_ex23-2.htm">23.2</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Marcum LLP</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">23.3*</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of K&amp;L Gates LLP (included in Exhibit 5.1)</div></td></tr><tr><td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOA">24.1</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 88.46%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Power of Attorney (included on signature page of this registration statement)</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 16pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">+<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) or Item 601(b)(2) of Regulation S-K. We hereby undertake to furnish copies of the omitted schedule or exhibit upon request by the Securities and Exchange Commission</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">To be filed by amendment.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 45pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 17.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Undertakings</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The undersigned registrant hereby undertakes:</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post- effective amendment thereof) that, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement&#894; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement&#894;</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 20pt; text-align: justify;">provided<font style="font-style: normal;">, </font>however<font style="font-style: normal;">, that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii)&#160;above do not apply if the information </font><font style="font-style: normal;">required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or </font><font style="font-style: normal;">furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act </font><font style="font-style: normal;">of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus </font><font style="font-style: normal;">filed pursuant to Rule 424(b) that is a part of the registration statement.</font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To remove from registration by means of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(A)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement&#894; and</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-3<br></div></div></div>
<!--End Page 19-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 20-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_301-part2_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(B)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x)&#160;for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant&#894;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant&#894; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iv)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for purposes of determining any liability under the Securities Act, each filing of the registrant&#8217;s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-4<br></div></div></div>
<!--End Page 20-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 21-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="ny20000330x1_s-3_302-sig_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">SIGNATURES</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York on August 13, 2021.</div><table cellspacing="0" cellpadding="0" class="txttab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td colspan="4" style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">By:</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Howard J. Federoff</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Howard J. Federoff <br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Executive Officer and President</div></td></tr></table><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 18.5pt; text-align: center;"><a name="tPOA"><!--Anchor--></a>POWER OF ATTORNEY AND SIGNATURES</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Each person whose signature appears below constitutes and appoints Howard Federoff and Sandra Gurrola, and each or either of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her, and in his or her name in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and any registration statement for the same offering that is to be effective under Rule 462(b) of the Securities Act of 1933, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.</div><table cellspacing="0" cellpadding="0" class="txttab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="header"><td style="width: 33.33%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">SIGNATURE</div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 41.03%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TITLE</div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.51%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">DATE</div></td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 20.51%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Howard J. Federoff</div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Executive Officer and President<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="font-style: italic;">(principal executive officer)</font></div></td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 20.51%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">August 13, 2021</div></td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Howard J. Federoff</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Sandra Gurrola</div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vice President of Finance<br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="font-style: italic;">(principal financial and accounting officer)</font></div></td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 20.51%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">August 13, 2021</div></td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sandra Gurrola</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Charles Cherington</div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 20.51%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">August 13, 2021</div></td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Charles Cherington</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 20.51%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Luba Greenwood</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Dennis H. Langer</div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 20.51%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">August 13, 2021</div></td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dennis H. Langer</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Erich Mohr</div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 20.51%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">August 13, 2021</div></td></tr><tr><td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Erich Mohr</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr></table></div></div></div>
<!--End Page 21-->
</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ny20000330x1_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.5.1.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">Exhibit 23.1</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman', Times, serif;">We consent to the incorporation by reference in this Registration Statement on Form S-3 and related Prospectus of Brooklyn ImmunoTherapeutics, Inc. (formerly
      known as NTN Buzztime, Inc.) of our report dated March 11, 2021, relating to the consolidated financial statements of NTN Buzztime, Inc. appearing in the Annual Report on Form 10-K of NTN Buzztime, Inc. for the year ended December 31, 2020 (which
      report expresses an unqualified opinion and includes an explanatory paragraph relating to the Company&#8217;s ability to continue as a going concern).</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman', Times, serif;">We also consent to the reference to our firm under the heading &#8220;Experts&#8221; in such Prospectus.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif; font-weight: normal;">/S/ BAKER TILLY US, LLP</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman', Times, serif;">San Diego, California</div>
    <div style="margin-bottom: 8pt; font-family: 'Times New Roman', Times, serif;">August 13, 2021</div>
    <div style="margin-bottom: 8pt; font-family: 'Times New Roman', Times, serif;"> <br>
    </div>
    <div style="margin-bottom: 8pt; font-family: 'Times New Roman', Times, serif;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>ny20000330x1_ex23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.5.1.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">


  <div style="font-weight: bold; text-align: right;">
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">Exhibit 23.2<br>
  </div>
  <div> <font style="font-weight: bold;"><br>
    </font></div>
  <div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif;"><u>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM&#8217;S CONSENT</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">We consent to the incorporation by reference in this Registration Statement of Brooklyn ImmunoTherapeutics, Inc. on Form S-3 of our report dated
      April 30, 2021, with respect to our audits of the&#160; financial statements&#160; of Brooklyn ImmunoTherapeutics, LLC&#160; as of December 31, 2020 and 2019 and for each of the two years in the period ended December 31, 2020 appearing in Amendment No. 1 to Form
      8-K/A of Brooklyn ImmunoTherapeutics, Inc. dated April 30, 2021.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">/s/ Marcum <font style="font-variant: small-caps;">llp</font></div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Marcum <font style="font-variant: small-caps;">llp</font></div>
    <div style="font-family: 'Times New Roman',Times,serif;">New York, NY</div>
    <div style="font-family: 'Times New Roman',Times,serif;">August 13, 2021</div>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo_brooklyn.jpg
<TEXT>
begin 644 logo_brooklyn.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M?_PD M(YM2T^]L8TT[Q!HZB_TQ#)!J=GIWY??\1.?[;14$?"7]F\@XP1HGQ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2^(5ZP>\\>_$;QQXVN6!# S>+/$^J:^_SC[X7^T @/'RJ%   K]]/^","_\
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MM[=-P_K^OO7WDE%1^=$2%$B;B0 N1DD] !U_^L">U24 %%%% !1110 4444
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M.:]+C+B/C',Z?!7$=7BS X;'5,MS&K1J87&QPF'P^+H9GF>6U,3@(1C+E=;
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M=WV=K:G]4]%?+_\ PAW[7?\ T7/X,_\ AA_$/_SXJ/\ A#OVN_\ HN?P9_\
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M@^DA_P ESE__ &3F"_\ 4[,C^N_ ;_DC\=_V/\7_ .H.7!1117\_'[:%%%%
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M?"FO:CXA/AG1)T@;3+/Q%?ZA!$L?B8IYLNIZ?9-<VE@9(K9KI[J*=(_!XHX
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M@/3_ !O%XEM;F?Q<OA^'3%O?#NO'36TV>+4GNGB%N;A;N$9?RL#^AX_LW_\
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M[V_UVX+MW^L\0>6NO#B_K\/K'Q%C$KKA+B=[:*GD5]>737/UW>Z3TVZ/P_\
MX+(\_P#!1'_@C1CG'[2^D9QSC'Q7^#6<^F*_I&B/#?[Y_D /Y5_$Y_P41^$_
M_!2KPM^UK_P3DT?]H/\ :B^#OQ(^+/B;XUV5A^SWXN\+_#'3_#VC?#CQ?+XZ
M^',%OK'BG38/"FG0^(;"/7[CP[J+VTMAJ0:UTR]@-O(+D1O^Q:?LV_\ !>8
MB/\ X*%_LT8!"D'X":#P0!R"WPUY4@@#:%7C<$7=BOMN(^&L-6X9X"HOBWA2
MA'"Y7G=.%>OB,[5'&*IQ%C:CJX5TLBJSE"DY.E/VT*,U4C-1A*/+-_*9%GN*
MIY_QG4_U;X@J2KYEE,Y4:=/*?;8>4<ARZFZ=?VF;TZ//.,55A[&M6BX27-)3
M3@?NM<G$+\@94CGZ&OYPO^#<Q0GPT_;7 X(_:QU]B">1G3 >0>@!S7M4G[.'
M_!>0(QD_X*#_ +-#*%?</^%"Z%UV,%.4^&Z. 'VDE64X! .37XW_ /!'_P"$
MG_!2KQQX,_:5NOV1/VH_@_\ !G1M,^/FJZ9\1;'QM\,=,\6W/B7QQ%9;KG7]
M+GN_"6N'3].>-F1=/B-D@=LF%>25DO#6&I\%\;T%Q;PI5CB:W"SGB*6(SMX?
M">PS#%S7UESR*%52KM\E%4J-5.2?M)4E9M9KGF)GQ9PC5?#F?4I4J/$25"I3
MRGVV(]K@L&FZ/LLWJTW[%I.?M:E-\LO<YW=']M5%?A%'^S=_P7G!.?\ @H1^
MS-T[? C02>H['X;FI3^S?_P7FP1_P\*_9H!P?^:"Z#Q^(^&F/QSQZBOBO]4L
M)TXVX+>W_,5Q M[?]4YTO^'K;ZQ<1XUJ[X2XG3[.GD-]+:Z9^^[VOT^?WK_P
M4Q(/_!/;]M, @G_AF3XS<#GKX&UD#]:^?O\ @B "/^"87[+H(P1H/B\$'@@_
M\+%\5\$=1^-?G3^V=\ ?^"SV@_LD?M*:Q\9?VX_@!XX^%.F?!3XBW_Q$\(Z#
M\%]'TK6O$G@VU\+ZE-XAT/2M4B\"V+Z??ZGIJSVEK>)>6K6\TJ3+<PL@:O*_
M^"9WP1_X*Z^+/V)_@AX@_9O_ &S?@5\,?@YJ6E^(I?!O@CQ9\'](\1Z_H4$7
MC'7HK^'4=:NO ^L2WQNM674;N&1[V=UAFAB9_E;9]K#AG"KP[Q&%_P!;N%'!
M\98;$_757SMX-361XFG]4<O[!^L+$RC>LH_5W2]FG>LIM0/E)9]BGQQAZ[X:
MX@C-<+XBFL,Z>4^WE%9MA9^W26;>Q5)22I>]6C4YY)J'(G-?UG5_"[_P<Y$'
M]M/X0D'('[/.D@D<X/\ PGGC7@XZ=1U]:_<D_LZ_\%YX0N__ (*$_LRY=UC'
M_%A?#_+$,1T^&?3@CUZ<8R1_,#_P6N\$?M=^!/VD/A_I?[97QD\!?&[XB77P
MAT^^T+Q/\/O!UGX+TO3O"S^*_$D4&D7=A9Z!H"W-['J4.H7#7!MI T-S$/-)
M3:GT_@CP_A<OX]P.+I\3\.9I4CE^:P6"RRKF\\5/GPW*YQ6,R;!4'"FFYU+U
MXR44^6,WH>!XM9QB<;P3F%"IP_G> A+%9;)XG&QRI8>'+C*,HQE]4S7%UKS>
MD>6C*-_BE%:GXW4445_:9_)(4444 ?KE_P $+/\ E*!^S=_U\>/O_5:^,*_T
M=J_SB?\ @A9_RE _9N_Z^/'W_JM?&%?Z.U?Q!])#_DN<O_[)S!?^IV9']=^
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MSSNME]LQ_L^I3>$Q%6K&C'!QQOMG7E5P]",=,1!Q<7-6C.]K)OXR_P""AO\
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MQ@O-^\]?QU?\&L;-)XF_;)=F9G;1/@Z2SD,S?\3#Q[]XA5R2268@ $GY550
M/[%:_B_Q7P6.R_CW/,)F.9U<YQM/ZA+$9C6H4<+/$5*N782J[8?#KV5&E24U
M2HTXN7+3A%.4GJ?UAX;XO"8W@[*,1@<OIY7A)K&QH8&E6JXB-"%+'8BDDZ]9
MNI5G/E]I5J24>:I*344K(_ __@Y!'_&MK6/?XU_"8'W'VO6.#7[*? (;O@7\
M%2>2?A+\._I_R*&B]!T'X"OQK_X.0?\ E&WJ_P#V6SX3>W_+WK'>OV3^ ?\
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MG ?Q'BKP]C_/K7^:@'8]=I.3R47/4]?EY^M?Z5__  67_P"48O[8'_9,X?\
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MKB\5LVJ91P-G5:C-PKXJ%'+J4DVFOKU:%"LTU9J2PTJ\HM-6DD[Z'\U(
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M'@M_"'PXOK[P[;S6**72.TU[5(=5\3+_ *III-7EF="=NW\ZAM(#,,XZXX.
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M-AX0KXFC3KUUAZ=:O3A5Q52,ZD:,*E2,:E><87G45.,I5)1C[TK-+5G]-O\
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M-?W1]''_ )-_BO\ LHLS_P#4+*C^/O'7_DM:7_8BR[_U*S([OX4_\E4^&/\
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MT(7GAIO+,PDDV_J]5^TP525K)1I5_:T6W=N6)IK9'Y&KM^4\!AD C:K<GU.
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MGE>7X6KB.53G1I8&IC)0>'I.,G7QE:KCG3PM'EDJE=4DXM-QE\1_MG?M"O\
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M_P#!;7KF:9YYKF?X;?9M,T:XN9I9II9;N?PG+X<GNY)F$D]Q-/<;0LBYS_\
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MK8BDDMV[)'Y%XW5X4N!,52DXJ>*S#+J-)-I-SC7^L2Y5U:I4:C:6MKO9-/\
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MDVZ^$BG.K@[M?'AM:E+WO>H<\(KEH)'["4445_,1_0Q^#W_!QO\ \HU/$/\
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MY!1116AB?Z\K_P '^^/Y&O\ ,U_X*]?\I*_VP\=/^%KW/_IGTGI7^F6W\/\
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MX(6?\I0/V;O^OCQ]_P"JU\85_H[5_G$_\$+/^4H'[-W_ %\>/O\ U6OC"O\
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MJ?AQ_P B!X&_[$WPS_Z9;&NVKB?AQ_R('@;_ +$WPS_Z9;&NVK_*2M_%J_\
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M(TNW_M-X;6QD\2^$==:SOY/#GB$6=O!%>/+#=Z;K$%M;PW]C)<1P:A9?V5?
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M_P!0M+5FW3JI_P!0DV\+QF)X8VC9'C:-D5D,;Y#1E<%2A'!7&".HY-?S"?\
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MBJT\=EM1KW9X3$R]HH0=FKX:I*>&FKN2]FI/2<6_ZH_^#;3]M[2? GB[QO\
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M,!IGAVQTZWE8;4DG\V147>17S$4 8GK]X8;E2"""& QE2"01G!&0>":<3GG
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MD7PDNKQM.^#NG?%O1(-Y@USX4^+-%U\W(4DA?^$>U2;0?%B2,@R%CT&=%?\
M=M*?E9_[6X8\8^!>):%-_P!KT,FQS454R_.:E/ SC)I7]EB*DWA,1!MM1=/$
M.;L^>G!W2_DOB#PMXPR"O**RROFV%O)T\;E-*IBX2BG9>TH4U+$T)-6;52ER
MZVC.>Y^.:, ""< XX[<9QQ[9X]*1G9B268Y[DD\?C[5]3>(OV&?VSO"MX^GZ
M[^RS\>-.O(Y3$\4WPO\ &,Z;P0"HN+#1KRV89/R,DSASZ  GTOP#_P $O_\
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MHI\?_$V9=K7-UX^\:"/5]4@N959EE_L"SDL/"\+QD1FVT:W*@Y9C^B]?YO\
MBAQ4^+^-<XS2$W/ T*W]FY7=W7]GX&4J5*I'5I+$U/:XNRZUV?W?X=<.?ZL<
M)Y7@)QY<76I+'X^ZL_KF,C"K.$NKEAZ7LL*WI?V&RT"BBBOSX^Y(+G_42?[C
M_P#H#5_DS?&3_DKOQ3_[*-XW_P#4EU.O]9BY_P!65_OY3\6&U1^)./QSVK^!
MCXC?\&_7_!2/Q-\0O'?B+2/ _P ,9=)U[QEXGUC3)9OBMH4$TNGZGK=[>6<T
MT$EN)()9;>:.22!@3"[-'EMNX_T7]'KB/(>'\9Q3+/,WR[*8XK#Y7'#2S#%4
M<+&O*E4Q?M8TY5IPC*5-5(.44[I232:3M^&>-V19QGF"X?IY/EN,S*IA\5CI
MUX8.A.O*E"I2PT82J<B?*I2C)*[3=G9.S/P*C[_A_6O[]O\ @W"!'_!.*PSW
M^./Q7/X>;H5?SG+_ ,&[_P#P4T&<>!?A3S_?^+>@#\OW2_CU[=._]8?_  1O
M_9/^,O[&7['5G\%OCIIFB:3XZ@^)WCSQ1+:>']<M?$>G?V3K[:6=.D34[-4@
M,SFUF,D&TM$-H+,2<?<>.W&'"N><%4<#DW$.49IC%GF!KRPV QU'%551IX?&
MQG4<:4I6C&56G%MNUY);GQG@[PIQ)DW%U;&9MDF8Y=A7E&*HQQ&+PU2C2E5J
M5\'.%-3FDG.4:<VHK7W7?8_5RBBBOX\/ZF"L[5_^09?_ /7I<_\ HF2M&L_5
M4DEL+J*%=TLT$L<:Y W,\;*!ST!)P3SM!W8.*<6HRBWHDTV^R3_KTZDS3<)I
M*[<9));MM.R/\CC6/^0MJG_81O?_ $IEK.K]T]1_X-Y?^"EUUJ%_=0>!OA28
M)[RZFB+?%S0%<QR3R.I*&'()!R%(W#@'G-4_^(=[_@IG_P!"+\+/_#M:!_\
M(]?Z3TO$?@!4J:?&7#<6J<+J6;X)-/E5TTZUTUU32::::OH?P;6X!XUG7K2C
MPOG;3JU&G]0KI-2DVFKQ5TTUJ?AQ17[C_P#$.]_P4S_Z$7X6?^':T#_Y'HK3
M_B(_ '_19\,_^'C!?_+OZL_*^7^H'&W_ $2V=_\ A#6\O[OG^#['^@^W\/\
MO#^M?YF?_!7K_E)5^V%_V5:X_P#3/I-?Z9C?P_[P_K7^9G_P5Z_Y25?MA?\
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M@?\ (9O*_>\R1CK(@[<NO7CCK[C\Q7\F>.7_ "<K//\ KQE'_JHP1_9OT?\
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MG_@A9_RE _9N_P"OCQ]_ZK7QA7^CM7\0?20_Y+G+_P#LG,%_ZG9D?UWX#?\
M)'X[_L?XO_U!RX****_GX_;0HHHH **XSXA>,[3X>^#M<\97]I=7MGH5J+NX
MM;/R_M$T9ECB*QF4B-3ND4Y=@..M<S\(/BUI?Q@\-3>)M)TS4-+MH=4N-*-O
MJ+6[S-+;16TLD@:V:2/81=* -P;*$D '-<LL;A88NG@95HK%U:,J].AKSRHP
MDHSFK)JT9-)W:=VDD[FRP]=X=XI4Y/#QJJC*KIR1JN*DH/6]W%W6EK=3UFBB
MBNHQ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI&. 3Z4 +17RW\6/
MVJ?"OPD\6MX1UCPWKVIW:Z;8ZG]ITZ73Q (KXS!(BMQ/'()$,#;CM*G<-I->
M:?\ #>?@0G_D3?%8!])=))&06' N<] 3] 37A8CB;(<)6J8?$9GAJ5>C-TZM
M.3GS4IQ=FJEH-0M?>32MK>VIZM#(\WQ-*%>AE^(J4JL5.G.,%RRB]FM=?^'[
M,^[Z*^$A^WGX"_Z$WQ6<\@^9I8X/3I<'COGWKUSXD?M*>&_AKI?@G5-2T'6-
M1C\<::VIV$-E+:)+:0K!ITYCN?.959PNIP#]V0,\=UW.EQ+D->EB*U'-,+4I
M854WB)PE*4:2K35.FYM1T4YOE3[IWT39-3)<UI5*5*I@*\*M?G5&$HJ,JGLX
M*I4Y;M7Y8-2:[6M=Z'TC15:SN%N[6VNT!5;F"&X56P619HUD56*D@LH8 D'&
M:LU[B=U=;/5'F>N_Y!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M28R3JQU%-.E!TO1(?W:7#8^UM&T9.\5\&?\ #M;]L'.1\-M-S@#GQOX/'"C
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MM9S(R[PT-Q+*D<JE/G#1LPVY)(Q@^*>(_$[^-_V8-=\6SP+!/X@^%FIZG<0
MEDBNIM&E^THH/&Q;CSA&N,*FU1TX^)_V>?@1_P +VT:76_&_BC7QX=\*R1>'
MM TJQN(%9?*C-[,$>XCG2TM8%O$C188EFE>1MT@BAB4>AF&>XNGB\%@<LP-/
M'ULPP,L9AI5,0\+2485*:DZLG"<HP5&3G%Q3DYV@U[R.'!Y71J4,5BL=BY8.
ME@L53PM:,*2KU)3G&;M3BIQ4FIQY7=N/+>5U;7]/?#_C;PIXK69_#/B+1->2
M!0TCZ5J=G?!%.-K.+::5T4Y #,NTGH2.:K^(/B!X*\*SQ6OB7Q5X?T*XF4-%
M!JNKV5E,X)P&$4\JRA6ZHVS#9'3-?F?\<?@U<_LV:CX5^(OPY\3:K#'+JZZ>
M3J/V>:[L[WR9[Y%:2*%8-1L+FVM9HY+&YMC&S(WFLPF!7T_X<?LD:'\0_"FF
M^/?B'XG\1ZAXE\8VL6O3-97-M%':PZD@G@CDDN(+N6\E2W>)F#F."%G,5K%%
M$N*XJ>?Y[6Q%?*J62X>.;851K5^?&\V CA*BC[&K"K[.%2I4J-N'L^6-G&3<
MGRM'7/*,KIT*./GFU7^S\0W3HN.";Q4L1!_O:4Z7M.6,:<;3]ISZJ44DW<^_
M=*UO2=<LXM0T?4;#5+&9RD=UI]Y!>6[$$ @2V[R1EN<[0V0,;L$X"ZIK>D:*
MD4FK:GI^F).S)"^H7MO9+*Z@$K&UQ)&KL"R@JI)&X''K^9/A2QUK]F3]I#1/
M ECK-QJOA7QE)I5O-!<*D2W%AKMU-8V5W+#&1!#JFG:C:E/M$$:"ZLT=)0OF
M(!Z3^WW@^%_A^.XUW5C[<V$&#CID%>#U';%;1XGJQR;,\=6P4:6893B/JF+P
M7MN:DZ_M*,5*%>,&W2G"O&I%\LFM8MR:;(61TY9G@,'3Q?M,)F-)5\/BHTFI
MNDX3;4J,I*U2,Z<H27-;3F5UH_OV*6.>*.:)TDBE1)(Y(V#I)&ZAD='4E65E
M(96!((((.#65=^(=#L+R#3[[5M-L[ZZV_9;.ZO[2WNK@R/Y<8@MIIDGE,DO[
MN/RXWWO\HR>!G>!Q_P 43X0'_4L: .?3^R[3(.>N1^=?GW^T8!_PU9\(<CK)
MX$&<<X'B^X) /4<A"<$9('6O4S?-IY9E^'QL*$:TJ^)P&']G*HX1BL96ITW)
MS4)-^S4VTE%<S23LF>?EV7K'XNIA75=)4Z&+K<Z@IMO#4IU%'E<HV4W%1;O[
MJ>EW8_1^YU.QLWM8[J[M;>2^E\FRCGN8H9+F8KO$4*2LC2R%>=D0=\<[:YS7
M_B'X'\+3K:>(O%GA[1;M\;+74]8T^RN&+#<H$,]PDOSJ0RY3D'/KCX\_;HO+
MK3?#?PWU"PGDM+VQ\8SW=I=0NT<MM/;Z<)8)HW3#J8W 8;2,<[LKN!SO 7['
M7AKQ;X6TOQ;X^\2>*=3\2^*+&#6[[[%>V\$4)U.-;N!&FGM[BXNY4MY8EEED
MD*E]PC1(P!7G8K.\V>9XS*<KRO#XJOA(86M*OBL8\+0C2Q%)2UY:52;J*K>$
M8I6Y4VVFK'7A\LP*P.'S#,,?5P]*O4K4HTZ&&]O5E4HSBI63J0BH<KNY-W3:
M2W/O'1]<TCQ!91ZCHFI6.JV,OW+O3[J"[MVX!P);=Y$SSR"P88^[BM0D $^G
M^?SK\KM'TO6?V7/VBO#_ (4TC5[O5/"WC,Z3'/;7)6(SZ7KFH2:;$;N-6:!M
M2TN]M0\=[$L;2QEXO+VRMCZC_:X^(VL^ /AD+?1+E[35?%>HC01>PEDFM-/:
MUFEU&:!LAHKB:W0V\4J,KV[3&9&WH*UP_$D/[.S3%YAAI83$Y+*5+,,+":K)
M5%",Z;H5(Q7M(5U*/LWRIW=FKIBK9++Z[@,-A*ZQ%',XPJ8.O*#I-PE.4)>U
MIMMPE3<9<R3:LM&>WZO\5/AWH5Y)I^K^-/"^GWL1VRVUWKNF03QMG&R2*6Y2
M1'!ZJR@CN!73Z/K^C>(K*+4-"U33]6L9B1'>:=>6U];G#;?];;R2(3N!  )Y
M!!P17P'\+_V,O"GB'P3H/B3Q=K>OSZQXDTVTUQTTFZM;.ULXM6A6]BA;S8;R
M6ZN D^^ZF>;;),Q5$5$&> M=*UC]EG]H3PWX?T;6KC4O"7B]]'MKBWO2J2W6
MG:SJ<FF-]J2!3;_;M*NT%Q%>I%;O)$=@"K).'Y/]8,XPOU7%YIE&'PV68JK0
MI^VHXWVV)PWUGE]E+$4O9Q@HWDE/EDW%O2]F=/\ 8^6XAXC#9?F-:OC\/"K/
MV=;#>QH8CV.M6%"?,Y*5E)P<])=4KJWZ2:Q\/_ WB*].I>(/!_AC7-0:*.$W
MVK:%IFHW9ABW>7%]HO+:>7RTWMM0,%7)P,DU^;'[8?A;PSX=^(?PYT[0/#VB
M:)9WFFR-=VVDZ58V$%TW]MI'F>"U@BAE(A?RP9(VPI(&!7ZIQL67)SU/48XS
MQQ].YY.17YD_MN?\E1^%_P#V"Y/_ $^P4N-Z%".08FHJ-)5/K67WG[.'.W+'
M4(2<I<MVW&4D[OJ/A6I4EFU*+J3<%AL8XQYY**_V>;5HWLM4G:VC/O"U^$GP
MM:")W^''@5V>.-V9O">A%B6122Q^P DYZDY8]R:^'OV[;2"RNOA+:6R1P6T$
M/B2*W@B01P000R^'O+BCC7A$C2,(BQJ,+@*A("G])+7_ (]K?_KA#_Z+6OSB
M_;\#F^^%X0D,T'BA5(8K\QET/:.",[GV+C(P2&_A%+C*E2H\,9C.E1ITY2AA
M>9TX0IN5\7AE:3BEIJ[MZ*[?<CAFI4J9Y@%4J3E[U9+FE*=N:A43:C)ZOEVM
MJ^A]JCXE^ ?#5EI.FZ[XQ\,Z5J']GV2_8K_6["UNP5M(3AK>:994)'(5T5@"
M-P&:[[2]5T[6K2*_TJ]M-0L9UW0WEE<Q75M,N<;HIH6>-U'0D'@Y&,BOAKPK
M^Q%X,O\ PYIUYXL\0^)KS7]2L;>\U":QNK2"UCN[J)9I!&L]K/-<",R;?-FE
M8RE=VU0VT>9_# :]^SU^TA'\*HM7FU;POXIN+>U82IY*L-5LC=:5J/V9&>&'
M4+:YC^Q7 A\M)XBQV 8-6L^S?!5, \WRJAA<#C\11PE.MA\8\16PU;$)?5X8
MFE[&G\;]R<H.T)7;5K)S_9678FGB5EV85L3B\+1J8B=*KA/84JM*BDZ\J-1U
M9N\%>4%)+FCUOM^H#,%4L2  ,\YQQ] 3^0->>ZC\6OAII-W)8ZCXZ\*65Y$0
MLEO<Z_ID4JLQ( 9&N>#\IR&(8'@C-?-_[:7Q'UKP;X)TCP]H4TUK<^+[R_@O
MKR!WBN4TC38;9[NVM94*R137<UU;PO+$RL(!*H/[WCE/!_[#_@F3PSI=QXGU
M[Q#-KE[:0WEW_94UE965M/<Q"7R(X);:YGD\IF!DFFNV>2428"QD(.G'9SF<
MLRK97DN P^+JX2C1K8VMB\2\/2I.O=TJ,%&%24ZDHKG;LXI:;ZF6%RS!+!4<
M?F6,JX:EB:M6GA:6'PZQ%6JJ/*JE22=2FH0C*2@M;RE=+9V^[-)UG2]<LX-0
MT>_M-3L;A2\%Y87,%W:RKZI-!)(C\8/RD@=\&IKC4K&TN+:UN;NVM[F]+K9P
M37$44UV\8W.EM%(ZO.Z+RRQ*Q4%=V-PK\Q?AS'K?[.G[2MM\,8=:EU3PMXKG
ML8&BN%2/SH-8MYVTV^^SQ-LCU*SNH8[>[F1/+E@CN#&%3"CO_P!N?4M0TIOA
M3JNE74]CJ.G:MK=W97=M*\4\%S#'IS12Q-&58%6(Q\V,<$$$XR7$\X9-F.8U
M\"Z>,RG%/!X[!1K<\8UH5J5*3I5U!*<)0JJI"7(K_"]FS7^PN?,\%@J6*4L/
MF-%8C"XN5)QYJ;IU)KVE+G?))2IN,X\[:7O=4C[1UWXD^ ?#-TMCX@\8>&]'
MO6('V34-9L+:Y&0#DP23B51@C&]%SD8R#D=B9XO*$_F)Y102>86&P(R[PY<9
M4)M.[>3M Y+8K\[/!W[$UGXCT+2_$?C?QAK7_"0:W:P:M?6]A%:NEO+?VT<Z
M07%W=+-<7DT0G*S3YB5G7Y$& 3U?[9OC7Q%X>\.>%?A[X=ENH(_%8GCU:_B6
M4326%B+2RM[!9X]OV=+VYN?-NF1P[0VSQJ-LQJEGF987+L?FF;97'!T:,:,\
M%0HXA8C$U_;<D8PJJ--JE-U*D825I*%I2;LKK/\ LS!U\9A,#@<>\14J2J1Q
M-:=!T:%%4X\TITW*7-4BHQF]5%MI16Z;^J;OXN_"^PNGLKOQ_P"$8+N)@DL$
MGB#2UDC<G:$=3=#:Q/ %=S9:A8ZE;0WMA=VU[9W S!<VLT<\$PR5)CEB9D8!
M@5)5B 00<$$5\*Z#^P[X'_X1^Q&O>(?$EQKMQ9Q37=S8RV=O9Q7$L*NT<-J;
M.8R16[DHDKS&6;.78#:!P?P!OO$7P=^/^M? Z\U235O#M_)=) TRLBI=IIPU
MK3=2MX=[);-<V!^SWUO$%C>><38S 0<H9]F^%Q. AG&4T,+A<RKT\+AZ^%QO
MUJ='$5H<]&EB*;I4^7G2DG*$I*$EK=&L\JRVO1Q;RO,:^*Q&"I3KU:5?"K#P
MJT*4E&I5HS52;ERWBU&48-J5M['Z1RZG80WD&G27=LE]<QR36]F]Q"EU/'%_
MK7AMV<32)&"#(ZH5C7)9A@BN3U3XG_#W0[W^S=9\:>&-,U ,$:RO-<TZ"Y1R
MVS8\,MPDBL'^4J5W!N"!7PA^VM?ZSI7Q'^&UWX=O+G3]:.AZG:6%U:3M;3+-
MJ%\+(+YZD;$E:<12D_,(I)"N#G/H&E?L,>!1I<']O>)/$]YK<T&^]O;2>SM[
M=;R106,=K):7#3Q1RDL!<SL9P/WK'<:UJYWFU?,,QR[*\KH8BIETZ*JU\5C/
MJ]%QQ%"%6ER)4:DY5'/VL)*W+&,(RYDY.*FEE>74\'@L;F&8UJ,,=2J3I4J&
M%5:K&5*M4I5.9NK"*II1IM/XFYM6:C=_;]CJ%CJ=M%>:==VU]:3KOAN;2:.X
M@E4_Q1S0L\<B^Z,P]ZLNZQJSN0JJ"S,Q"@*H))))   !))( QR0.:_,OX#WF
MO?!7]H'4_@E+J,FJ>'=5GOK>#</+1)8M)FU[2=1B@WRBTGFLE>TU". QQ22,
MDSKF-17H_P"VM\0=?T31_#'@#0KF:R/C,W<VIW,4K12S6=K);V<.FK(A4QP7
M=Q=A[QE= T<(A9@DKD.'%%*.28S-<3A:E*OE]>I@\9@H355PQT*D*2H0K**C
M*,Y5*;53E2C&5Y+17F>15/[3PV I5X5*6,HPQ6'Q3BX0>$G"53VTX-\T7",)
M\T+_ !1:3/JB]^+_ ,+].NI;*^\?^#[6Z@<I+;S^(M+CE1PVTJR-<AE(;*D$
M#!!':NXT[4[#5K6"^TR[MK^RN4,EO=VEQ#<VTR @9BFA=XY ,X)5B >,U\/>
M'?V&O ?]@V(USQ!XFN-:DM8Y+NXL);"RLH9Y45VBMK5[2X9X( PCC>::2255
MWR-O9C7FGP2N]>^!W[0^H_!B75)M6\-ZQ,]M#'(J1?OI=-.L:9JD<"F1;>Y:
M,-:7<<#K%*&5Y%+(C+G3SO.<+B,$LXRO#8;"9AB(86C6PV-]O4H5ZJO1A7IN
MG'^)LW&5HRTUNKW+*LMQ%+%/+,QKXC$8.A+$U*6(PBH0J4:37MI4:BJS;<$^
M:,913DKZ7V_2+4O$&BZ/+##JFJZ;ITMP&-M'?7]K9R7&PH'\A;F2(S;3(BGR
M]^'8*<$BM=6W#.." 0<@Y_+C(]B0>Q-?FK^W3A_%/PLW \6VJ$ \$$ZCIY/0
M\9VKG'!  Z5^D=L<QC/95 ]AC.!Z#VKU<#FLL7F>;Y?*BH++)X6,:BFY.K'$
MX>-:\H\JY'!MQLG)-).][H\_%8!8? Y=C%4<GCEB&Z;BHJE["I&FK24FY\Z?
M,[QC9Z;:F=+XCT*#45T>76-,35F*JNF-?VJZ@Q:,2J%LWE6X8M&RNH6,[E8$
M9'->*_M">-=.T[X4^/X-*\466G>)+;1)/LD-GK4-IK5O=FXM#'Y"6URM]!.8
MI&93&HDVL",KP?D[QNH/[=WA\8^]J7A?IG)QX/@+ $$$<8) (SZ'%=A^T?\
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M5Y2E)I))+5MMI)+5O1)LX&U%.4FHQBFY2D[1BDKMMO1)+5M[(_E3_P"#FO\
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M_>$/VT_A3K\<2:^-4\'WKY$L5]9W.IV,;!02/[1TN"8A<_+NDLXNQQSQ^1Y
M/4 \8Y&>,YQSVSS]>>M&!Z#\A3SOQCXYXES9YQQ!C<)F>+G2I4*DI8'"X2$J
M-!-4X1I8*E0Y&HNRGSR?5IL7#WA)P5PGD\<CX<P.*RO 0K5L13@L?B<9.-;$
M.,JLG4QDJTIIRC=1;22LE97/W]\/?$3P1XM1&\,^*M!UO>3\FGZE;33+@J"6
MMO,6X&"P!'EYR0!UQ7:#GV^O^>_Y^N#7\YH+Q-');L8I(Y%D5XV,;J5R05>,
MHX8-@@J\9SSO'0^V>%OVC/C1X1$,.F^-;Z[LHE4+I^N1P:Q:!4;"Q*UXDUS;
MJ%YQ;2Q@\;GW M79@?$O#3=LQRZK0>G[W"U(UX/:]J<_9U(V=]%>X\7P)7CK
M@L="JG?W,5!TI*VRYZ2J)M]W",4U:_?]QJ*_,_P?^W;K, 2#QUX.M;Y H4W_
M (;NFM+@G=\TCV5\[PL2O(5+F$9Z$=OI;PO^UM\%?$C)%-XCG\/7+E%^S^(M
M/N=/1&.,!KZ-KO3< ]6^V+P,L #Q]?@>+.'\?RJCF5"G.3M&EB6\+4;M>RC7
M4$WT]UR5UHWH?-8OA_.,&W[7 UI06]2BE7IVO:[E2<N5/^^HO75)GTU16/H_
MB'0?$-LM[H&M:7K5F^0MUI5_:ZA;D@9(\ZTEEC!7H06!!X(S6ON4X&1D]!D9
M./3UXY^G/2OH8SA.*E"491:TE%III]4U^?3<\>2<6XR3C).SC)--/3=.SZH6
MBBBJ$%%%% !1110 4444 %%%% 'A7[3/_)"?B3_V &_]*[6O)/V(?^217O\
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M]C?>?^FS2JV="Y_8Q.,'/PAU/_TWW77/0Y!'/>L;]A3_ ));KG4?\5?>=?\
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M4ZCKIQA/EORR<$I)/=--*S3/BKQI_P GX>'?]G4O#'_CW@Z '\@*^P/VE?\
MDAGQ'_[ +?\ I7;5\*'QGHGCS]M3PUXB\.7)OM)E\1Z7I]O>J/W5TVE^&WLY
MKBW+!2UM(\<BQN1\X02QED*L?O\ ^/>C7^O_  =^(FDZ7#)<ZC=^&+\VMO&
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MK]FLB, >0ZLRG/8G&#@CV'6?V'/A'J=_->V-_P"*M$@N7#R:=97VG7%I&H&
MELVHZ7=7,8'\ EN)PA^YM!P'_M&_ SQS\4/&G@37?"XT4V/AU$743J=_-:39
M75[:^S;QQV=P)088W'+H1( IPIWC[+'0<8X''I[5X.'R#"X[.^(:^:Y92KT*
MU;+YX.KB*2DIJGA.2JZ4_BY8RM&2NHMZVOJ>K5SC$87+<FI9?CJE"I1H8R&)
MA0FXN,I8ISI^TBK)OE;<&TVELTM#RWX:?!OP)\)]/GL?".FR0S7>S[?JM[-]
MKU>_$8;RTN;QD0^3&79HK>!(;>,G*Q@C-=;XL\'^'/'.AWGASQ3I=OJ^D7R@
M36URH8JZ@B.>"4?O+:YA)WPW$#1RQ/\ ,C@DYZ:BOK:>#PM+#+!T\/1AA5!T
M_J\:4%1Y'?FBZ=N1J5WS)KWFVW>Y\_4Q%>K6>)J5JL\0Y*;K2G*53G224N=O
MF3222L]$M#XCO?V$OA5/=/):Z_XSLK9W9S:"^TJX9%9F<I%<S:0;DH&8X\Z2
M=S\Q=V9B:^A_AG\&? GPFL9[3PAI\T5Q>;/M^L7\R7>L7XB_U:7-X(8AY,9R
MR6T$4-JC$NL(8DGU6BN'!Y!DV KO%8/+<)A\0XN'M:=**G&+WC!N_)%[-0Y;
MK3;0ZL5FV98VDJ.*QV)KTDT_9U*LG%M--.2TYFFDUS7LUH<SXK\'>'/&^AWO
MASQ1IEMJ^D7Z!)[6ZC5P&4AHYH6(W07$3@213Q%)8W 9'! Q\G3?L*_">6_\
M]=<\:1VA8.MC_:.D2^6!_P LXIYM$>81=,;S)(, ^9D U]KT5IC\FRO,Y0GC
ML#A\3."Y8SJ4XN:C>_+SVYN6_P!F]O*Y.%S+'X*,H83%U\/"<N>4:=248N5D
MN:U[*5DE=*]M#P;1_P!F[X5^'M2\%ZOH6D76DZCX'NI[O3[JTNQY^IRW",L@
MUZ>>&>XU)0[>9'^]@>(CRHW6U+6Y]W90X*L,@@@@@$$'&00000<8(/8FG45U
MX?"87"1E#"X>CAX3:<H4:<:<6XQ4$W&*4;J,5&]M4M3GJXBO7<95ZU6M**:C
M*K.4Y).3D[.3;UDW+U;/F3Q;^R/\&O%VK7&M2Z7JFA7MW,US=#PW?PZ=:S7#
MNLDD_P!BELKNUAEDD4/*]M% 9'RS[F))]ETCP%HFB^ K?X=6<FH-H-MX?D\-
MQRW$\4NI'3Y+5[0L]S]G6%[D12,5D-ML#X)B(&T]M17/0RG+,-5Q%;#X'#4*
MN+C*&)G1I0INM&3;DJG(DI<S;;TNVV]V:U<=C*].E2K8FM5IT)<]&%2I*2IR
M5K2C=NST2]%;8\F^%'P:\)?!RQU;3_"<^M36^LW5M=W?]LWMO>.DMK ;>,0&
MWLK)8T*$EPRR$MR&4?+5OXF_"'P-\6M+CTWQAI9N'MM[:?JEE(+36-->1"K-
M97RQR/&K Y:!TEMY&PSPLP!KTZBM%E^!C@UEZPM!X)0=-864%*CR-N7+R2NK
M<SOW3U6I/US%?6?KGUBJL5S*2KQFXU5))134XV:?*DO-:/0^(+7]A'X5Q7@F
MF\1^-+FW5U;[*UYH\;LJ](Y;A-&$K @8+*L<H&2DB'!KZR\&^!O#'@'1;?P_
MX5TR'2M+MS(XABRSSS2D&6YNIWS-<W,NU0\TSLVT!%VHJJ.MHKFP&293EDIS
MP& PV%G47+.=*FE-Q=KQYW>:B[*\5*VB[(UQ>98_'1C#%XNOB(1:DH5*C<5)
M;2Y=(N2UU:OJ]=3SCXC?"GP5\5-*72O%^E_:A 7>QO[:3[-J>FRR *\EC>*K
M/%Y@"^="ZR6\^U?.ADQ7S.O["/PL^V&9_$?C5[8MDVQNM#$C#=EE>X_L(L0R
M@H[! S G!4G(^WZ*6-R')\QK+$8W+L+B:RY5[6I33FU'X5)JW.DM$I7LM%H5
MA<US'!TW1PN,KT:3U]G"?NIO=Q3NHM_W;:Z[ZG!> /AIX-^&6D?V-X0TB/3[
M>1UEN[F1C<:CJ-PN0+C4;^0&XNY0&8)YC>7"I*0I&GRUWM%%>C1H4<-2A0P]
M*G1HTXJ-.E2A&%.$5LHPBE%+T6^NYQ5*E2K4G5JSE4J3;E.<Y.4Y2>[E)W;?
MJSC?B!X9O?&/@KQ7X6TSQ)JW@[4/$GA[6-!M/%>@_91K7AV?5["XL(M:TDWL
M%S:#5-,>X%YIS75O<6\=Y%#)-!,BM$W\XD__  ; _LK7$K3S?M!_M"33R%FE
MG>;X?23RN[%WDEF;P>\LCR.=TCNQ+MAF);D_TVT5]5P_QAQ+PJL2N'\VKY8L
M9*E+%>PA0DZ[HJ2I*;JTJC<::G/EBFH^\W:[N?.9WPKD'$<L//.\MH9B\*JD
M<.J\JMJ2JRA*KR1IU(1O4=.'-)IM\L5>RL?S&G_@U\_94 /_ !D!^T(./^>O
MP_\ Z^#3_(_0U^Q'[ G[ OPD_P""?'PFUGX6?"K5/$/B2/Q+XMOO&7B+Q7XN
M.E2>)-8U"YL=/TJQM;J;2=-TRW&GZ/INF06NFVBVX6!I+R<YGNYW;[JHKLSO
MQ XRXCP+RW.\_P ;C\#*I3JRPU5484IU*3O3G-4:5/G<'[T5)M*3YDKV:YLH
MX)X6R'%K'Y1DV$P.+5*=%5Z7M7-4ZG)SQ3J5)I*3A&]K.RM>S=RBBBOCCZD*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&YQZ9R>W3)Z]N0*_#;
MX]Z5JTWQG^),L6F7\T9\5:@\<D=G<NC*PC(9&6)E93V()4T45\+Q]AX8C+,)
M";FHK&J7N2Y6W[&HK.Z>G_ /K.#ZT\/C\34ARN3PC@^975G6IMZ)KMWV/(O[
M+UO_ *!&I_\ @!=?_&*/[+UO_H$:G_X 77_QBBBOR;^RL-_/7_\ !B_^0_J[
M\K?HG]I5_P"6C_X _P#Y+^KORL?V7K?_ $"-3_\  "Z_^,4?V7K?_0(U/_P
MNO\ XQ111_96&_GK_P#@Q?\ R']7?E8_M*O_ "T?_ '_ /)?U=^5C^R];_Z!
M&I_^ %U_\8H_LO6_^@1J?_@!=?\ QBBBC^RL-_/7_P#!B_\ D/ZN_*Q_:5?^
M6C_X _\ Y+^KORL?V7K?_0(U/_P NO\ XQ1_9>M_] C4_P#P NO_ (Q111_9
M6&_GK_\ @Q?_ "']7?E8_M*O_+1_\ ?_ ,E_5WY6/[+UO_H$:G_X 77_ ,8H
M_LO6_P#H$:G_ . %U_\ &***/[*PW\]?_P &+_Y#^KORL?VE7_EH_P#@#_\
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M_P  +K_XQ1_9>M_] C4__ "Z_P#C%%%']E8;^>O_ .#%_P#(?U=^5C^TJ_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>logo_brooklynx1.jpg
<TEXT>
begin 644 logo_brooklynx1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M (>G1/\ YW]'_$5%X1_Z,L\6?^'IT3_YW]>I_P 05\4/^B4Q'3_F/RGKR_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U_NG\/YB
MO\^S_@XJ_P"4E'BG_LDGPS_]-=Y7^@F_W3^'\Q7^?9_P<5?\I*/%/_9)/AG_
M .FN\K]W^CK_ ,G$_P"Z%F?_ *<PA^,>.G_)%0_['>7_ /IK$'X5)]Q?]U?Y
M"G4U/N+_ +J_R%.K^Z3^/8[+T7Y!UI H 8 ?>4J>_!]">5/'#+A@>012T47?
M?S^?<=D]U<^O/V*?#_[8?B'XRV=I^Q#<>-X?C/IFF7/B.VM_A]XNT/PEK$VC
M:-);B_,Z:]KVA:5KNFH;J!M1T2]CU2"_MFE6ZL9;<SY_KK^#-A^UA^UAX,M_
M@;_P5N_X)H7_ (\TIA9Z=H7Q[\,0_"]];T.*2%'FU/7=,\-_$)_%.@:DMTJO
M/J_PZ$4<\<C6]YX99/M$4W\;_P"R=^T3XJ_9._:+^$OQ^\'S2KJ/P_\ %NGZ
MKJ6GH91#XA\,/(;+Q5X<NTCPTEIK'AZZU&RE,1::W,Z7D*&6U17_ -/3X>?M
M"?![XF>!_"'Q \->/_"-QX=\:^&]'\4:-<R>(M%@E;3=:L+?4+07$+7WF6UR
ML5RD<]O)B6&99(W&5R?Y;\?<PS+*,QRJK1R'+:U/%8;GR[B+"T\?AN(,LS##
MSYJL(9A@<32M#DG3KTH582A*,JD91<J;DOZ+\%L)E^88#,*-7.<;1JX?$6QV
M18BK@Z^38[!5U'V51X'&4*B4G-5(5JE"4)<SCSR:E!+^/K]N+_@W*^,G@C4;
MSQE^Q'?7/Q?\$W/EW#?##Q;K>AZ#\2M$:9I#<C2=;UH:!X;\1Z=;1I#':1:A
M<Z7K80,"-3D7<WX=?M%_L,_M9_LDZ/X;U_\ :,^"^M_"O1?%^L7NB^&-3UO6
M/">HG6=4T^R.H7MC#%X;\2ZQ+;R6]OB9)+NW@26/"J#(>?\ 3^_X69\./^A\
M\&?^%/H?_P G5_-#_P '(/B+PGXL\%?L366E:UX>\0QQ_M"ZJVHVMIJ>DZM
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MNGB#EN7T^$<WG3R[!QG&.!:E#"4(R2_M/ W2E&G=<RT=NF]S]AM,_P"":_[
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M_521T( \/:?DX/.!U8]%'+8'-?T]QLIR,\XSC!Z%W /3V/\ DBOIN(,[S>'
M/A[5AFV91K5L3QFJU2./Q,:M54\QRV--59JJIU%34I1ASM\BE*,;)L^<R3+,
MN?&O&\'EV"]G##\*SA!X2AR1E/!8[G<8NG92ER1YFDF[*^R/B7_AVG^P#_T:
M!\ __#>:%_\ (U(?^":7[ !&/^&0?@'@]<?#S0O_ )&K[@R/?\C_ (49'O\
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M -2Z_K^J/HO_ ._\8_\ 8'DO_J3CC^=/I"?[GPO_ -A.:_\ IK GFE?U0_\
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MMFBZ[H//IW'44PNBG!."<]CV&3R!CIV[]!S3'N((@3)*D:@$EG.U0!R26.
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M:2RMI#L^/GQ=5 7BC9@J#Q?M4%N1C  PJ@* !H?\,;_"S_H:/CE_X?WXN_\
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M]^+O_P UU?5^1ZC\Q1D>H_,5^??VIF'_ $&5O_ O3R\E_3/N/[/P7_0-2_\
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MXQ:\/B+A_+^)LIQ649E3YZ&)C[E2-E5PU>.M+$T9-.U2E*S2T4XWA+W9-/\
MR&W5X)1'(NQ@TB[&^64%&9=LD1)>)D*/',DF'CGC>)U5NC@%<ABH!4,N<G)5
MT="I((( )612I5A)&C!OEQ7]47_!>/\ X),R> ]1\3?MO?L\^'[:V\!ZG<KJ
M?QU\!:+9^3_PB_B#4K_R9_B1H]I&Y$FAZ[=7<0\66-G;1C2-1"Z\L:Z;=ZO-
M9_RM' +8+!MQ5U.0593M(QV&0>W7/X?Z+\&<897QKD>%SO*Y\O-&-/&X5S3K
MY?CE&$JV&J_"W*+?-2DERU*,HU(NTG;^%.*N%\QX3SC$93F$6Y1_>87%1BU1
MQF#E*2IXBEJU:2BXU(2=Z=12IR;Y;O\ <3_@CC_P5;U?]ACQ^/A3\6;S5=7_
M &9OB%KED=10S3W4GPJ\03O=PGQCHUO/=QQ?V%J1F@/C2QB\UY(;*WUBTC.H
M65_!J'^@5X?U_2/%&CZ9X@T#4;'6-#UK3K/5M(U?2[J*^TW4]-U"!+FROK&]
MMV>"ZM;JVDCG@GA=XY8I$=&(.:_R,#D\ G.<@Y7@\8(W@H", C<-N[DCDY_I
MH_X(=_\ !7,_ ?5=&_9$_:,\0WD_PD\3:M#8?"CQWJ=X7A^%NM:BT%K;^$]3
M:4321^"M;U!A)97(N&M?#&IW1A<1Z/<O<6OX;XV^$SS2&(XQX:PR>8TH.KG6
M745KCJ5./O8[#4U9?6J<8MUZ44Y5X^\OWD;3_7_"3Q*>73P_"^?XC_8*LE3R
MO'59:8.K)VCA*\Y7?U:K*T:,VU[&<N1I4FG#^X"BH8)5EB5UD5P1NW*RL,$D
MC#  $ $ ,.& SDYR9J_CK<_J@*CE_P!6Q/( R1Z[2#CWZ=._3O3]R@XR,X!Q
MD9P<@'Z9!_*O%_VAOCGX'_9O^"_Q'^-OQ"U&*Q\*?#GPMJGB34<RHMS?26,#
MFQT?3D)W7&JZSJ'V?2],M8EDFN+VYABBC=F K6AAZV*KT<-AZ<ZV(Q%6G0HT
MJ:<IU*M6:ITX1BM7*<Y1BDMVT95Z]'#4:N(Q%2%*A0ISJUJDVHPITJ<7.<Y2
M>BC&*;;>B2;9_FK?\%(M T;PO^WY^V+H6@)#%I=I^T1\4;BUM[<*D-L-4\3W
MVK7-K'&O^K2VU"]O8 H 0>7MC50I4?%->B?%[XD:O\8_BO\ $SXM:^Y?6_B?
MX_\ &'Q U0DQD)?>+_$.HZ[/"ACBC'E0M>^7#MW1+"L:1!%7;7G=?ZD9+A:V
M"R;*,'B9<V(PF5Y?AL1)OF;KT,)1I5FY=7[2,KOJ];O<_P Z\TQ%/%YGF6*H
MJ*HXG'XS$4E'X53K8BI4@HWM[JC))*RLELMCZF_8;U*ZT?\ ;0_9-U*Q+"[M
M?VCO@O);E,[O,/Q$\/+C@@X*L0P&=P)4@JQK_4_C0H@4L6(XW'J?<^YZGW-?
MYBO_  2R^'][\3/^"AW[(7AFRA\Y(/C5X3\77Y.XHND_#^[?QQJN\ 8,<UEX
M<N+7+?)YDR@G.*_TZD!"\ECDD_-U';'/;CC\Z_D?Z3%:E+B/AS#IKV]'):]6
MJK)-0K8V2HINUW=TJK2;LEJM9._]-_1_IU%D6>U6G[*>;4X0=W9SIX.E*HDM
MDU&I2NUO?78_D+_X+Y?MV_M??LO?M7?#KP-\ OCSXQ^&/A/6/@GI/B;4=$\/
M)H_V6ZUR?Q=XJTZ74)&U#3+Z;S7LK*T@8"41XA4A Q8G\-5_X+"?\%,5S_QF
M!\3V_P!Y/#!_]U^OT7_X.;O^3V?A/_V;KHG_ *G?C2OYP:_8O"[A#A7'< \+
MXS&\.9)B\57RZ-2MB,3EF$KU:L_:U%S5)U*4I2=HI7;>B1^5>(?$_$>#XUXB
MPN$S[-\-AJ&.]G1H4,QQ=*C2A["A+EA3IU8QBN9MV2ZG[7?LB?\ !5C_ (*%
M^/?VI_V=O!'C/]JGXCZ]X2\6?&?X?^'?$FBWB>'3::MHVL>(]/M-0L+D0Z)#
M+Y-Q;S/"^R975&9D8-C']/?_  41_P""V?P$_8>O]1^%7A?2Y_C;\>[:Q66;
MPCX=UFPMO"O@N2Z7-HOQ!\31O=W.FW_ENER/#>E:7J.K/;%&NY-,CN+6XG_S
M\O#'B;7_  7XBT3Q;X4U:\T#Q-X<U.TUG0M<TZ5X-0TG5;"59K/4;*>-DDAN
M[25%EMY8W5XY$5D8,H(S]0OKS4[^\U+4KVZU'4[ZZN;N]U&]GN+J_OKB\F>Y
MN+N\O)W=Y[BXN)99969WD+LS2,Q(-=.>^"_">?Y_EF85<'A\ORG+\'6I5LIR
MG#4\"LQQ=2M&<*N)JX=4W&E2A&SC37M:E^3VD(+7+)?%?B3),FS# TL3B,=F
M>-Q5.I2S/,\15QOU'"PH\DJ6'I5IRO4G4;FG)^SAK+DG)JWZC?M.?\%E?V]O
MVF-8O'O?C%K7PB\)NCP6G@7X,:AJ?@G2K>%F#!KW5[:_G\2:K>J1\UU<ZO'$
MV75;*&-C$/S4UWQMXS\5W4MWXK\6^)O%-Y<-<37-[XD\0:UKE[=2LDDSO<W6
MIZA=3REG7/RNB@DD+G&.8 X..B 9]%'1<GMD#CN<4Y 6=0H))64  $DEX)54
M#'=B0!ZDC%?I64\-\/Y+0IX3*LGRW 4:?+&,,-A*-*;A>*O.I:5:HY;RG4J5
M)R;;G.4FV_@\SSW.<WJRQ&:9ICL;6=Y<]?$59*+UE>$>90II-OE4(Q4591LD
MDO\ 4,_X)MY_X8'_ &0R223\ OAN23ZGPY9'OR?JQ9B<DDYK[:KXE_X)M$']
M@?\ 9#P0<? 'X;#@Y_YENR]*]]^.OQP^&_[.GPG\;?&?XK^(H/#/@/P'HTVM
M:[JLB/-*L2/'!;6=C:0AI[[4M1O)[>PTZQMU::ZO;B&!%!?(_P SLXHU<1Q%
MFF&PU*=:M7SK'4*%&C!SJ5:M3'5:=.G3A%-RG.34812O*321_?N55Z=#(,LQ
M.)JQI4J63X&OB*U62A"G"&!I5*M2I.32C&*4I3DVDDFWL=;X[\?>#?AGX6UK
MQMX_\3Z#X.\(^'K&;4=;\1^)=4L]&T;3+.!6>2:[U"_F@MH@ I"HT@=W*I&K
M.RJ?Y8_VQ/\ @YA\-:)J&J^$/V,OABGC*6RFNK#_ (6S\5$N].\*W-U"'4S^
M'O!.E7UMKFJ64;@&&[UW4] >Z.!'IC6[_:A^$7_!2C_@IW\8/^"@OQ,O)[R^
MUOP3\!M O/*^'GP?35C+I\26<ES"GBOQ;':K!:ZOXNU-79YWE2XL]$4&PT=_
M*$]Q<?F(0F.,$@8!SEN.@!R3@= ,XQQTXK^KO#WZ/^78/"X?,^.(/'9A6C3K
M0R:%1QP6$C**DH8JI0J*6+KZKG4*L</!WBE634S^;>-_&W'XG$SR_A&2PF!I
MRE">:5*498K%ZVY\-3K0E'#4;-2A*=-XANTG['X#[D^-W_!2W]NC]H'5M2U/
MX@?M*_%&&TU*:>3_ (1CP=XHU3P/X1L8;AF9K&RT/PQ=::OV)%*QQQWES>3;
M$'FSRN6<_%E_KNM:M.]UJ^KZEJMS(=SW.HWUW>W#/C!=IKN:=V=OXG<L[DDL
MQ8DG*/ !/ ) !/ )/0 GJ3@X'?%*%8\@$]^!V]1Z_A7]$8#)LIRJE'#Y;E>7
MX"E&*@J>$P6&H+E5K)^SI1<MD_>;;:3=WJ?AV+S7,L?5E7QV8XW%U9-N57$X
MJO6GK;:52<G%:))1LDK))(W-$\5>*?#-Y#J'AKQ1XD\.WT$HFAO-"UW4]'NH
M)EP4FMKC2[FSFMYD(RLD3JP/K@8_0;]GC_@KG^WY^S7K.G7OACX_^+O'NA6"
MF.3P3\8=2U/XB>%[^%E2/RKI-3U"'6HFB1"+>:PUFRFC)RSR*H2OS;R,D9&1
MU'<?4=OQI2/4?F/\:SS+(LESFA/#YKE.7YA1J1<)0Q>$H5GROI&<X.<&KW3A
M*+3U33U+P.<9MEE2-;+<SQ^!JQDI*>&Q=>E=Z:R4)J,TTE=34D^J/[DOV'?^
M#BSX(_&C6M"^&?[3WA&3X#^/-9N+2RLO'=I?+JWP>OKNYDA@B36=6O)8-7\#
M22,Y=7U>#4-"MX!YEWXA@;:C?TC:7JEAK-E;:EI=Y:ZAI][!%=6=]8W$5U:7
M=M.N^&XMKB!Y(9H)4(>.6.1TD4AU)4J3_D4*!D 8&6!X1#D]MP8%2IZ.6R A
M;@]#^\?_  2)_P""Q'C7]C#Q/I7P5^-^LZ]XQ_9D\1W6GV<#W5U+J.J?!:Z>
M:>.;7O#$$Z27EYX5N[BZ@E\1>%DF L8DDU3P_:07/VJRU3^9_$CP"PU/"XC.
MN!85H3H1=7$\/SJ.M[6E%.52IEM6H_:*I3BK_5)RG[17=*<96I/^@> _&JK.
MOA\IXNE"<:THTJ.=1C&FX3DXQIK'TH)04)2?*\3324&TZL%!2JK_ $!**Q/#
MOB'1O%.A:-XD\/ZG9:QHFOZ98ZQH^J6$Z7%EJ6F:E;17EA?6<Z$K/;75K/#-
M#*O$D<BMQG%;=?R:U*+<91<91;4HR34HR3LXR3U33T:>J>C/Z5C)2C&46I1D
ME*,HM2BTU=.+6C33NFM&M0ICN$4L2 !Z^YQ3B0.I QR<D< YP?QP?R/I7XF?
M\%=O^"K_ (=_8*\#1_#SP'':^)OVE/B)H5Y=^$-(GE0Z7X%T*8W.FP_$#Q()
MH+A+I8;^&2/0O#Y3.LWUM)-=R1Z7;74TWJY'D>:<29IA<FR?#2Q6/QD^6E33
M480C&SJ5ZTW:-.A1B^>K4;M&*TNVD_-SC.,OR'+L1FF:8B.&P>&AS5*DM7*3
M^"E3BM9U:C]VG".LI/HKM?7/[;/_  4C_9F_8-\+0ZU\9/%#ZAXIU5'_ .$6
M^%W@XZ?K'Q$\2RB*22-[;0Y=0LUTS2Y&01G7M9N+'258F..XGNMEK)_)/^UA
M_P '&'[6_P 9EUCPW\!=&T']G+P;>S20V^M:9+-XH^*+6BRLT3_\))=R1:#I
M;R@"*>'3/#TTL:LSKJ$)"D?A)\1?B5X]^+_C;Q!\1OBAXOU[QSXY\3W9O-=\
M3^(]1GU#4M2E*A5W2SR,(((T&RWLK=(;.Q@V6EI;P01+!'Q> N64 $(4! &0
MA7:5![*5 &T<8XQ7]M<$^!7"G#E"AB,]H4N(\YM"=2KBX?\ ";AZC2;AAL$W
M*G4A&5U[3$NK.5E)*"]P_D7BWQDXDSVO6P^45JN1Y4Y.%*GAFJ>/K035I8G&
M1;J0<]Y4L-[*,$U'GJ/WW[)X_P#VDOVA?BM<S7?Q,^.7Q:\>3SM(TB^*/B!X
MHU6TS*=T@CTZ?4_[/MU<]4M;:",KA"A4*!XX+FX,BRO-(\JYVR^9(LF2<Y8J
MP#$<!25W  9)8%C7+*!DL ,XR2!R1G')ZXY^F/6E[X[X!QWP0"#]""#]#7[1
M0P>"PU*%##8/"T*<$E&G1P]&G!);)0A!15KKI?;N?EE7&8NO-U:^+Q-:I*_-
M4JUZM2<EUYISFW+5=6]5Y'KW@7]H'X[_  ONQ??#7XT?%3P%<@QL#X4\>^)M
M$MR\1&QY+.PU&"SF*J-NV:!XVZNC8Q7[+?LI?\'"O[9WP/&G:!\8ET;]I7P1
M;7@:^F\7/<Z/\3+>TF>,%+#QEI@.FW8ACC;R(?$&@7CR3.S/J448$8_ HD ;
MB0!@')( P20#SVR",^H(ZU*NW!#8X/(./0=0?8YY^M>%GO!O"_$E&5#.\CP&
M,33M4>'IT<3!RM>5/$THPKTY65TXSW2NK7/6RGBKB+(:L:^4YQCL*X.+]E&O
M.IAJB3TC4PU24J%2+NU:4'O\C_3(_83_ ."H/[,O[?GA^XE^%>M7GA?Q_HL$
M1\4?"?QY)I6F>.-)9HR9+[3K2SU*]MO$WA]9 %77=%GGMXQ)!'?Q6%Y+]C3]
M&(Y!(NY>5(4JPZ,&4,&4@E64@@@J2*_R1/!WC3Q;\./%GA[QSX"\1ZSX/\7^
M&=2MM4T#Q-X>O;C3=7TB_A=?+NK2^M'CGA8@!)F#%7A++*LD99&_O4_X(X_\
M%<=-_;<\,0?!+XP36^D?M-^!O#T4MW>*UM;Z?\7=!TF"VMKWQII5O!;VEOIN
MOP.Z2>)?#\$9MDDE?5-(SICRP:?_ "'XJ>"F(X0I5L_X=G7S'AZ+<\3AJC4\
M=E$&TN>I-)?6L'S24?;**J4=JRE%.M+^GO#GQ:H<3U*.39W"E@\[FN7#UZ:Y
M<)F4HJ-XQBV_JV+=W)T6Y4JB5Z4HM^RC^]=?'W_!07_DQO\ :V_[-Z^+'_J%
MZO7U^IRJD]P#TQU'ID_S/UKY _X*"_\ )C?[6W_9O7Q8_P#4+U>OQ7(?^1YD
MG_8WRS_U-H'ZWF^N49H^^78W_P!1JI_EK*<JI_O(A/XHM#=!_O)_Z&M*. !V
M"H![#8M(W0?[R?\ H:U_J8_/LOR5OP/\Z#^ZO_@V._Y,A^*?_9Q/B'_U!/ =
M?T?U_.!_P;'?\F0_%/\ [.)\0_\ J"> Z_H_) ZG'UK_ #?\5O\ DXW&'_8Y
MQ'_I,#^\/#7_ )(3AG_L6P_].U0KR+XY?'#X<_LZ_##Q?\7_ (K^(;+PUX%\
M%:7+JFM:E=31I*47$=O8:?;R/&VHZOJ=W)!8Z5I=NWVK4+R>.WMDDF9(VVOB
MI\4?!'P9\ >*_B?\1O$-CX7\$>"="U+Q#XDUV_E"6VGZ9IMLUS-)L4-+<3R!
M!#:6MNLES=W4D-K;12W$T4;?YX__  56_P""HOC?_@H-\4OLGAU]8\)_LY^!
M[ZX3X>>!)KP(WB&[BFEC'Q!\6VT4'.O:E;A!INERO/%X:L76Q2<7,^K7%WT>
M&WASF7B!FZHTU/#9+@ZD'FV9<NE*#M)87#\UHU,97C\$+VIP;JU-%&,L>/N.
M\!P5EOM9..(S;%1DLMP"E9U))I/$5VM886DVN>6\Y6IPU;E'TW]J[_@NS^VO
M\8/C+K_BOX&?%+Q9\ OA7&B:5X-\"Z"="N;E](M+BY:'7O%-U=66IK<^)M9$
MHFO/L,L.G6<,<%C;Q/\ 9S=7/S=_P^&_X*8_]'??$W_OWX8_^4%?FRVT* N/
MO$\8_B)9O?EB2?<D]ZC\N:9XH;>.26>9TBBBB1I)99)9$ACCCC4%G>261(XU
M4%FD=44%B!7]R83P\X'P.%H86GPMD4Z6%HPIQJ8K+<'B:\HTXQ7/6Q%>C.I5
MJ2MS3G.5V[O8_CW$<<\7XNO6Q-3B+.8U*]6525/#X_%4*2<Y7Y:-"E5C3IP5
M^6$(12LDMS]+;?\ X*_?\%.KZX@L+/\ :V^*UU?WD\-K96=I:^'+BZN;J>18
MH+>W@A\.M----(RI%%$CO([!$5F8"O[4_P#@E9\&/VX_"WPP?XI_MT?M">._
MB'\0OB'I-A<Z+\)];.C_ -C_  RT.Y,6H6O]L&TT+3+R;QY=1/&NK6Z3MINC
M1LVF!;V[CFN(_P WO^")7_!&]/@W;^&_VNOVI?#>GWGQ5UG3;75?A3\--7L4
MNX_AIIU]:)/:>,=?BDEEMT\=ZC!*?L>DS6[GPA X\V?_ (2"65-._J(55085
M0H]  !P,=O:OY'\8.+.$L7B7PYP;D618;"82HUF.=8'+<)1JXNM!V^K8*M3I
M1<</2DE[7$TW_M$ER4VZ"YZO]-^%W#'$^'H0S_BS.,XKXFO!2R_*,5F.,J4\
M-2J17^T8VC.M*%2O4BTZ="I%_5T^::59\M)0, #). !D]3@=3[GJ:_R8_C1_
MR6#XL_\ 95_B9_ZEU_7^L[7^3%\:/^2P?%G_ +*O\3/_ %+K^OL_HO\ ^_\
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M#?EDTN3,HNU]$KV225M%;^?>3]@[_@M.RD#_ (*KZ#G(^]\*K #]=#Q7P/\
M\%,?V2?^"GWPR_8J^,GC+]H;_@H'HWQJ^$NDP>$CXH^&]M\/++2)O$)N_&WA
MVST@KJ::3 ;;^S-9GL=4;$@,BV9B_CK^P!6SV*GT; /UX)X[9]:_(3_@NX[)
M_P $O?VD]N/FA^' .0",?\+2\'#H01T)KZ'A#CC-<5Q5PSA9Y=PO"&(S_)Z,
MYT.$^'L/7C&IF&&BY4J]'+X5:51)WC4IRC.+M)232:\/B?A'+:'#?$&(IXWB
M*52CD>:3@J_$_$.(I-T\#7DE4P]?,JE&M%V]ZG5A*$E>,HM-GYA_L.?L<_\
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MQRQ'LE'X:*J*E&3<U!3?,? K?L)_\%IHDWR?\%5M  WQJ3_PJK3N3)(D8/\
MR _5@2/3@=A7XB?\%M/V??VZ?@K\//@/J/[7/[7FF_M,:%KWCOQ;9^#]'L?!
MUKX9?POJEEX:L[G5-1DN8=-M&N5U+3WBM!&')C*9.%)!_N_N&C6/,HRGF0+C
M_:::-8S^#E6/L*_&7_@LC_P3Y\4_\%"/A[\)/ W@7XK?#_X=>-_ 'BCQ7XF\
M,:-X]^VQV7CB74_#MKIM]IEO=Z8+G4[!M.C2*ZDO+31M<2)9U%U:PQE9:RX
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MY<?LG_#_ %V[C^$?P%UF\L?'5O:7!2P\9?%N$E=3%["8RM[9>!"3I&GK<*T
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M._DN[?3K%1?W%JFJ71CL/Q4+YW#!.2QR3DD,Q(+8 !8@Y;  )SBF'DYXSZX
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MMI\ )/"%Q<1-&NL^$_'OCRPU6)B#MF$E[X@U*UED1L$?:;2=3C!4@D'^9O\
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M)T3XB>$=8U74F$3.3::;I=M-?WCKD+:Q2RY5$9Z]@_X)/#'_  3>_8P&<X^
M7@+G&,_\2V/G&3C/ID_6E6DGX6X&-US1X\Q[E&ZYH\V081+F5[J_*[76MM+H
M]2FG_P 1$J.SY7PAATI6]UM9U-NSM9M)J]NZ/T'N?]4/^NMO^MQ$*_EX_P"#
MG7Q+X@\(_##]C[Q#X5UW6/#>N6'Q<^($^GZUX?U?4=#UBQEB\%Z>_FV6I:;)
M%=6[<#)CD0D@$9/-?U#77^J'_7:V_P#2F*OY7/\ @Z7_ .2+_LD?]E5^(_\
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M3V5S%)#(MO\ !7X=:=<*LJE':WO=,\.V=[:3!3\ES:W$-Q$<-'*C!2/YA/\
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M<FVU/1-71!::MI=S'+;WMJ2A194@GC\H*E<9P1C'F(<QLPX=4/#'8W#9 Z@
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M3XK_ !MT&QOXD?9]IT;P?H6N>)YXI% )EB_MB#069,!0P1BP("M_"ALPH/&
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MQ,_8)N?B%'81-XA^!/Q&\+>-;#4E1#<V_A_7I9O!GB6R,Y995L+P:[IM_=P
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M9#?W8U_&_P!(G'U<3Q]'!RDW0RW)L!2HP>T)8KVN+K-=+S=6#;26R6MC^I_
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MDQ?&C_DL'Q9_[*O\3/\ U+K^OZH^B_\ [_QC_P!@>2_^I../YT^D)_N?"_\
MV$YK_P"FL">:5_5#_P &L_\ R6W]K?\ [)A\./\ U+?$E?RO5_5#_P &L_\
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MXN?^IKJU?*E?5?[=G_)ZW[6'_9POQ<_]375J^5*_U'X<_P"2=R#_ +$F4_\
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M>&:M9T/K%3V+TTUI\NVG8^T?^"<GC.X^'W[>G[(?BNVF:W-G^T!\-=.NI%V
M-IGB3Q'9^&=8A<N0%CN-*UB]@8Y&/,ZXS7^HG$NR-5_KD#V![C'0]Z_RX/\
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MWQ- '4Q@PP>)%\*1-$" 3%+_ ,(N65APQ8L"V<M_GZ A<.Q  9<9[G(P/Q)
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MOZ\>^NBLK^EEKUZ'\QKIT_KN. )( &20Q [D* 6QZ[003CH"":_H)_X) ?\
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M/C/\5=&OXOV=/@WK6G:C<Q36RBQ^)_CRPN[74-.\%QM<H\-UH6F"*'4?&.P
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M^SB?I\7?! _GK/\ C_4?Y=%%'_$LF0?]%1FO_A)@_+^]Y/[_ "#_ (F S?\
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M+:ZA@N(Y88_0Z_RZ/V0_^"@'[4G[$&MW6J? /XAR:+I.KM&_B'P/KUC:^)O
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M_P#@V8_Y,<^)'_9Q?BC_ -0_P+7UWTA?^3>3_P"QWE'_ *3B3YGP._Y+R/\
MV*,P_P#=<_HYHHHK^#C^RPHHHH _DI_X.F?^14_8^_[&;XP_^FKP17\=M?V)
M?\'3/_(J?L??]C-\8?\ TU>"*_CMK_0/P+_Y-ED'_7W-O_5MC3^*/&3_ )+_
M #7_ *\9=_Z@T HHHK]=/RX_UYG^Z?P_F*_S[/\ @XJ_Y24>*?\ LDGPS_\
M37>5_H)29VC']X?EGFO\^O\ X.*<_P##RCQ3G_HD?PR_/^R[S/X]*_A;Z.O_
M "<3TR',WZ_O,)MYG]@^.G_)%0_['> _]-8@_"Q/N+_NK_(4ZFI]Q?\ =7^0
MIU?W2?Q['9>B_(*<IP?Q3_T8A_I3:4=0.<EE  !/\:GM[ G\* =K.^UM?0_T
MLO\ @C7_ ,HQ?V/?^R:7G_J8^)Z_36OS+_X(VQR1?\$R?V0$ECDB<?#.=C'+
M&\3A9/%GB26-BDBJP62*2.6-B,21.DB%D92?TTK_ "]XJ_Y*GB;_ +*#./\
MU88@_P!#N&;_ .K?#]]&LDRI-/1IK 4+IKHT]UT85Y3\=;::\^#'Q6M;:&6X
MN;CX>>,8+>W@4M-//+X>U".&&)5#,TDLC*B  DLPQ7JU4-4O++3].O;_ %&6
M*"PLK6XN[V:X*K!#:VT3S7$LS,"HBCB5GD+<!02>,UX^&JSH8G#UJ</:3I8B
MC4A"S?/*%6,E!I:VDU9VUUTU/3Q=&.(PN)H3G[.%;#UJ4ZB=G"-2G*#G?2W*
MGS7OT/PA^,T]I^QE^Q7X5^!FE-';?%/XY67]J>-;FUQ!=V%K/;V3^*59HG$J
MPV5L+7PC8,\L@E474B(S,Q3\;5=MH)Y+98MC&YFY9E X4%B2%  7H  *^C_V
MK/C=/\?/C=XN\<B:5] AO)M \'P2L7%OX7T6YE@TN8+OD2*;4P9=8N1$0IFO
MBK%FB!KYQ=N2V3@#KSP /SXQ7^BOAWD.)R;(OK69OGS[B#$5,]SZK*-I_7\>
MHU5A4^E+!47##4X)**<)R2BYR1_F+XG<187/N(OJ>5-4N'>&L+3X?X>HQLJ?
MU# ?NIXIK9U<;B%5Q,I\J<H2I1E?DYG^NO\ P3^5?AI^S?\ M:?':X&V6W\/
M)H.ESN-K,^B:!J=[.EO("")+C5/$.GQ81EWS6\8 W+7Q+^QBSG]JCX'/)GS)
M/'VG&0$DD-Y-SNR3R6+%B['JQ)P*^V_%Z_\ "I_^"6G@C1=H@U'XT>);#5+]
M"##++9:EK<WB.,;/D=U.CZ-IT;A@P*L PVD8^(?V+V9OVI/@27!#GQYIA?./
MO&WG)Z9Y&<-W+ACSG-?$94GC\I\9.(I7DLRQ.?Y;AJFZG@N'LFGEE+E=DN1U
M?K#22WO[TFFS[_-K9;G?@5PPO<_LK#\/9KB**3M#&\3<04<TK<W]Z%&.'A%M
MW47)/=']<PX 'I1117\-G^@4=EZ+\CS/XM<?#3XJG_JF?BK_ -,&OU_*+^RC
MXP_X5[^T5\%?$YF,-M9>-]$TV^D9B%&FZ_-'H%\SE2N0EO?M*,G;O0;E9<J?
MZNOBW_R3/XK?]DS\5?\ J/Z_7\9MO<3V<EM=VS%+BV>&>VD!*LES$Z/;.C @
MHR7"Q.K@@HR!@0P!']1?1_P,,UR'C_+*JYJ>/HY;@YQT5UBL'FM%V;T3]Y:]
M+7/Y$^DKF53)N(_#K-Z4G&>65<PQ\6H\S?U3'Y)BG%+KSNA%6]#[Y_X*3^"W
M\(_M4^*=0CC06_CK2="\6P,@\N.26XLWTN]PQ 7=]LTHL2>6WD\Y!'Q;X+\7
MZYX \7>&O&GANYDL]=\+:U8:SI<BR.L?VNSN4E"3C>H:"=1);W*[E\RVFD@W
M*C9'ZC_\%)[>+QW\-?V6?CK9*)8_%'@]=+O9XU$BROJ6EZ-XETPRR@'"V\[:
MS#B1N-[Q@#YB?R/;HPSD$,#\AD+ @@@)D9)SD!CM_O<5^W^&6)6;^'^38;'0
MA6GA<%B,AQ]"HKIRRROB,KJ4:T6G\="A3<HRNI1GU3N_P?Q7PG]C>)6>8K 2
ME0IXC'X7B++\12;3MF='#9M2K49JW\.O6FXRBTE*-EJM/WQ^)?A71?C7X^_8
MT_;/\ VX-MXA\=_#_0?'=K;QHTEDLFLBWLYKF5%+O/HFJ)?:!>?:$<A6L2C1
MQQ9E_8R/[B<Y^4#.,$XXR1V)[BOP*_X)6?'&WL=?U[]G[Q9,LVG^(KD^+_ S
M76R>&V\06+1W&K:9 9"3%+>M#;:QIVQ-\=W:W;(RNJ9_?9!A5'HH_E7\=^*6
M S'(LZPW"^,YIX/A^AB*&18F=W/$9%C,75QN A.7PSE@U7J8.4H[N@HM1Y5?
M^W?"+,LLXBR#$<68'DIXSB*OAZ^?X:&D*&?X+!T,!F$XQT<8XSZO2QD8R3;5
M?G4I*=VR:3RDWX!^>).<_P#+25(\\>F[/UJ6H+G_ %7_ &UM_P#T?%4Y. 2>
M@Y-?F1^KG\F'_!TQ_P B1^R'_P!C;\3_ /TR^&:_CFK^QO\ X.E5=O O[(9"
ML1_PE_Q-0L%8J';1/#NU"^-H=]K!%)W.1A QP*_CE92I*L"""001W'!P>AP<
M@D9&01U! _T!\";+PSR))IVK9I?NG_:>*=GV=K.WF?Q1XR*W'^:W^U0RYKS2
MP-!:=U=6OWT$HHHK]?/RX*_LP_X-8O\ DE_[87_8_?"/_P!1;Q;7\9]?V8?\
M&L7_ "2_]L+_ +'[X1_^HMXMK\;\>O\ DVF;_P#89E'_ *LL.?J7@W_R7^4?
M]@^:_P#J!5/ZN****_@,_M8**** "BBFODHX7[Q5MOUP<= 3U]C]#0_Z_K\P
M/\L;]NM1_P -I_M8MW'[0_Q:7';!\::P?Z5\I5_<W\8O^#;WX,?&;XM_$SXM
MZI^T?\4-$O\ XF^./$WCK4=(LO"7A2YM=.U#Q-K%YJ\]G:7%S*DTMK;-=M;Q
M/*@E=(DD?YF;/FY_X-<?@23Q^U'\5\=MW@KP:3^?G>M?W1DWCIX<X/)\IPF(
MS/'QKX3+,!A:T5E..DHU</A:-&HE)4[-*<)6:T:5^J/XZS3P>XZQ6:9EBJ.7
MX.5#%9AC,11F\RPD6Z5?$3J4VXN?-%N,TVGL[W/XK**_M3'_  :X_ G//[4?
MQ7Q_L^"O!H/X'SJ4_P#!KE\"2>/VH_BQC_;\%^#6.?;$_':O2_XCYX:?]#3,
M.G_,GQ_6W_3OSU]&</\ Q!?C^Z_X3L%;37^T\'I>W3GOI?\ !['\5=%?VI_\
M0N/P)[_M1_%;'MX*\&@_@?.X-*?^#7+X$GI^U'\6/??X+\&,/;&)_K1_Q'SP
MT_Z&F8?^&?'^7_3OS_!A_P 07X_O_P B[!6TU_M/!Z;=.>_7\#^*NBO[4_\
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M*?$$$,?]N^"+Z]TU;9-2U7Q'=O:Z]\2]5+&&6X>#PS;*(;+4K"W_ #3C7/\
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MO$FF7FB^(?#6L:AH.O:/?0M!>:3K.EW4]EJ&FWD3(ABN;2ZMYX)(R%(>)L#
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M&K7=Q$S'+* T3KLVLP\H1<Y)"^V?L9?\G3? O_L?M._]$W%>)+\./B&NP+X
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MT\=C<;3R_!1J^PC5G2G6G5K63<*5*#4I<J=Y.Z2772S_ %=ANX+A2\$BRH"
M6C97&3[JQ^IST'-8'B?P9X8\:V<&G>*]#T[7;"WG6ZAM-1@$\,5PL;QK*B$@
M!U1V4'/0GZ5^6/B/P]\6OV2/$OAS68/$DGB#P[JE\=\-I)=6VEZLMI&);W2]
M0TN[EN8[6X:SR]O>1-YA4N8F+6Q!_5/PGXCM/%GAW0?$=AD6>NZ18ZM;J_#I
M#?6T<Z1L,=5WD%O5?>M,JS>.;RQ>!QN J8'&X3E^M8'$.%>#I5$G"<:D8*E6
MIR;LW%<M[::JZQ^6RRZ.&QF&Q<,7A,3S?5\914J4E4IM.4)4W)SI5%:]F[M7
M['S=\:_@O\*M ^%/CW5](\!^'-/U.Q\,ZE/97MKI\<=Q;7"1AHYHI#N*,O/(
M]>AZCP']C3X<>!_'7AOQG=>+?#6E>(I;/7K&*SDU:U2XDMH'L6>2*(DX022'
MS&VX!;MQD_9O[0G_ "1CXC?]BMJG_HFOFC]@;_D4?'?_ &,&G_\ IO:O!QV#
MPD>-,CHQPN&5*>5YBYTU0I*$G"5/EYH<O+)KGEK)-KHU8]/"XG$?ZL9E-UZS
MFLRPT5-U9\Z2C1=E+FO%-R=TK)Z7/KCP[\)_AWX/OSJWA3P?H>A:F8'MC>Z?
M:+;S&WE9#+"9%R=DFQ=PP0<#CBOSM_9_^7]K?Q>Q.0E[\1QT"LQ.I2$!5X#-
M^\4';SP2P ()_54]O<_T)_I7XBVND>-O$7Q[\8:#X"U"XTK7-:\3^,M.EU"U
ME%I);:3)JD[:J\ET@$T=OY(B\Z2-Q+]V-'7Y14<6SAEV*X9GA<)SJGFTYPPN
M%A3IRJU/9T5&,%904G)IN4DU9/JV/A^,L71SVG6Q*A[3+8QE7Q$ISC"$*JDW
M)J\[)+1+=VT/VL.J6(E\C[1#YN<>6)H"V<9QM\S=GL!CDD#O5U6#C(Z5^8VI
M_L1_$"RMKC6=,^)5EJ&OQ(UPMH+/5-.DN[A,^7&-7.JR7"REL")Y(&4/M!(!
MS7HW[(WQF\4:[J.M?"KQQ=W6H:YH,4USIVHZA,)[Y8-.E@LM2TB\F*A[B2RD
M=98;F5V>17DB.1"#7K87B/$K'X7 9OE%?*:F/<X8*K/$T<51KUH1YG1]I1C%
M0J.*<HQDM4M&<&(R>@L)6Q>7YE1S&.&Y98J%.C5HSI4YM1C54:MG.',TI./P
MW39]Z$A02>@^G]2!_GCFJ4FI6,+F.:Z@BD !*231(X!SC*,X?G!P=N..M?(_
M[6OQIU;X<>'])\.^&+B:R\2>*GN =2@*^=I&DVK(ES=6ZF.17N+B:1+:(\,B
M&65 752/GCP[^QM\2/%^CV7B+Q/\0TTC4]6AAO7L-1M]1\07L:3QF1%NM2DU
M: "X)?>(;:)XXT<*0K( UX_B'$T\?5RW*LIKYMB<-2A5Q;AB*6%HT%5^"FZU
M6,XNJU[W):]KVU087)Z,\)3QV89A2RZAB*DZ>&YZ52M4KNFTJDHPIZJ$6[.3
MTNTK[V_4>.XBF4-$X=6. R_,#[Y&1CWS@G(&3Q4C,J %C@$X_'!/\@:_)WPQ
MXF^)/[+/Q7TKP;XOU>76?".K"UFDMEO9Y=/GTR^N6L$UG3DN_.-A)93QS274
M"-%(YMY4<-$5D/VM^U5J%[8?!#Q9=:;>75C>1/I+0W5G-+;W$.=5M$+K-"Z.
MF0W4'!Z$,N0=,%Q'#$X#,\37P=;"8O*/:K'9?4J4YU83I4O:KDJ0]R4*L=:=
M2T;ZOE5C/$9-4HXK T:>(I8C#YE*DL)C*<9QISC4J1IMN$GS*5.3M.-]';4^
MB)+B&)#)+(L:+NW/(RHB[>I9F( &>,DXS3;:[MKM#);3Q3H#M+12)(H;&=I*
M,P#;<-M)W $$@9K\BO"?AWX\_M-V"E_$DL'ASPY;V^C_ &K4;V[M-.N+J&UA
M5M]EIL9_M2]EB$4UW--$41S\PRV!]P? SX<ZK\ _AUXKB\6ZM8:@L-_?>)YK
MBPEN9HH[*UT:U6XC#W<-M(L@:RE91M"?..F3G+*>(<3FU:-2&3XO#97.A*M#
M,L34I0A-QW4:2;FXZ-\^L6K23M>UYAD]++H2ISS'#U\?"M&E+!4(59-)RLVZ
MG+R*2ZP=I)M*Q]+R7$$2EYI8XD'5Y)$1 ?3<6VY]LY]JCBOK.<XAN8)6QG;'
M+&YY.!PK''X\<BOR3TNV^*W[77C77[NWUZ30/"FG/$WV2:ZN9--T:TEEGCM+
M6&SLV@:^U*6.W-U.)U$2R2.IE1%&[1\<_LX?%/X):+/\0/#'CY]131&M[G49
M=*CO=(O[:W%Q#&MS]GDNKFUN[>!Y4:XC=Y ( SB$_=7@7%V+K49X_!</8W%Y
M13E4OCX8C#1E4ITI<LZM'#.3JU(74G%Q3NHN]FFEVOA["TJD,+BLZPN'S"<8
M-8.5&M-0J5(WC2J5XKV<)WT:>J;LKJS?ZR9Z^W7I41G3)')(+# QSMX/?ITY
M.!SGIDCP?]G/XJS?%[X=6VNW\8@UK3;F70M=561A-?6L%K<)>J%4 +?6EW!<
M;0"(I7F@!)B)KX,\0^,OBW<_&WXF?#/P'XBU&"3QIXSN]-@B-U+_ ,2Z&TFN
MY9)K2Y)=]+MH[5)TNF@:*0Q,BICY#7IXWB;"X7 Y9CZ5&OBZ6:U84<+&@DJL
MJE6E.I0AR5'%7J3C&E*[7*Y<VR.#"9'B,3BL=A*E6EA:F7TW4Q$JZE[-0A6I
M4JDG*";7)&HZB]WWE%K1M'ZRG4+(2>2UU LO(\HS1^9D=5V!BV[_ &<9JV&#
M=""/4$'GKCV.,=?45^9-U^Q'\0VAEU1/BA:W&O&(7'E26NLIYUV5.476WU,7
M<3+EMLJ6Z@MMW[5)KK?V4OC!XN3Q3JWP<^(-W>WFJ:?%J,FEW6I7$E[>V=SH
M[6]M?Z+)<NH-S;[8Y[NSFED:X+"93NB,;UCA^(\5''X;!9MDV)RJ..E*&#Q-
M3$X;$4:E6,;^PG["<G3JR2O%2^*Z7IK7R6B\+7Q.79E0S%86$9XJG"C5H5*<
M)-1]I&-57J04GK);)-OS_0H\?I^IQ5*34+*%S'-<PQ. "5DEB1L'/\+.&'3H
M0*^7_P!JSXRZG\+/!ME8^'IA;^)?%LMS;:??J%8Z79V212WU\@D1D:9O.@MK
M<MM\IYS<YVPDU\L>$OV2?B3\1]"LO&7BGX@KIEWKUM!J5K;ZE%J.OZDUI?01
M74$]]<MJ-LL,TZ3!_(B3;%&8U*JX9:O,.(:]+,)Y7E65ULVQM"E3K8J$*]+#
M4\-"JFZ:G5K*4>>2L^11;M*-[)W(P>44JN$CCL?F%'+L-5J3I8>52E5KU*]2
MG;GY:=%.2@N9+G:M=-.S5C]3HKB*90\3K(C' =&5U)R <,K$'KG@D8!(S3WD
M6/!;OGN!T&3U([>F3^%?DM9ZG\3?V2_B1HVAZWKCZYX.U9H+BYM8KFX_LR_T
MS[1]FNKFVL[EIY-/U.Q8K-L@?9*-J2LROD?>7[0FJR?\*)\=ZEIEY-"[>'H+
MBVN[662WG19[W3RKQRQ,DL9,,X(964X;D]16F"XA6)P>95:V#JX3&Y33JRQF
M!J5(3G%TZ3JP4*L5R2A5C%J,^5+=I-69&*R>5"O@84L32Q.%S&4(X7&4XSC"
M=ZD:<^:G.TXRIMWE%[K9L]V656SM#'! Z=<C.1GKVSCD9!( IY(49) ' R2
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M/]!\OP.'RW X3+\)3C2PV"PU'"T*<591IT*<:<5ZM1NWU;;"BBBN([ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH , ]1FF>5'DGRTR3DG:N2?<XR?Q_E
M3Z*+M;.P63W5QABC((\M.?\ 97_"D>-'P&4$#ID ^GKGTJ2BAZM-MZ;==[7W
M]!679?<,\N/^XA^J@G^5'EQ_\\T_[Y7_  I]%.[75_>PLNR^Y" !0 H  X
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M]OXJ/#_PY) R-6\0\XR<?8=.[_F,>]?3/[-__)#OAG_V+%K_ .A/7S'_ ,%
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M7J7["1!^%GB CD?\)I?8/9@=,TM@1W&,D$'H1^->7?M[@_VS\-"P.UK/7UW
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MC2*%RN)'/7.>U?(8WQ#R/#-QPZQ&.FFTG0IN%)V:5_:UE#3>SA"::5[I6O\
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MDS!<DAKFUR2,$\A?I7PQ^V3\'M?*1:E?ZIX7N),8&KZ;<2VP8L1M^VZ<+V%
MO +7"PKDYSL&X?C](A<  @8.>:55*IMX) /J!R2>Q![]B#Z&OJL#QWQ#A$H5
M:]+&TT]%BJ2=1I6M^]IN$]-=[ZV?2S^=Q7!^38F[A2JX6;MKAZC4/7V<^>-_
M1K338_H.\.^,?"WBVV%[X9U_2=<MNAETV^@N@C<?*XB=BAY'W@,9]^>DW#.,
MC/IGFOYV;#4-4TJ5;C3-0O=-N$</'-IU[>64J,/XEEMIX7WCM(Q:0<C=@G/M
M_A?]IKXV^%7C^S^,Y]8MX\#[)XC@CUF&11@;)9I1'?E<#&Z.^BE.YLR\\?78
M+Q+PD^6&/R_$4&VDZM"<*]-7WER-TYI+M>3=]]#YS%\"XN"E+!XVA72VIUHR
MHSM_B7/!M_\ ;J5M3]N**_-OP9^W@\4<4/CWP=YCACYFH>%YQ#&5.Y2PT[5[
MN3<0Q7*C4T.,E2YPC_2WAG]JSX*^)A&J^*DT2XD !MO$=K<:0T;G&$>XD66Q
M))) *W9!(X)'(^OP'%.0YC98?,L/&3=O9XB7U:IS::<M;E3>MDX2DFU9.^A\
MUBLAS?"-^UP-:45?WZ,?;PLMWS4N:R6[YE%I:M):GT=167INM:5K%LEYI.H6
M.J6<@)2ZTZ[M[VW( !&)8)'4[@01C/49(K3!R,^OOFOH(RC))QDI)ZIQ:::[
MIK1GD---IIIK1IIII]FG9KYBT444P"BBB@ I&Z' R<' &,GCISQS[\>M+10!
M^;7PN^&'Q#TG]J+5O%VI^$-<LO#DVN>-[F'6KBQDCT^2&^?4#9L)@S)MNA(A
MA<A0X9=N"V#[-^U_X+\5^-_ 'A[3?"F@:GKU];>);>\GM-/MVGFC@&FZC"\L
MB*K,B!Y(T+'"[G ZGGZ_HKYRGPWAJ>6YGEGUBO*EFE?%5ZLVJ:G"6*]GS1@E
M%1<8^S7+S)MW=[V1[4\[Q$\=@,>Z=-5<OI4*5.*<N6:P\7&+G=\UY7ULTMK=
M;^1? K1M5\/_  F\!:+K5C<:;J6G>'K:WO;&ZA:WN+:X627=#-"X5D<*5)5A
MD#'KQX#^VGX#\8^.M%\"6WA#PWJOB*6PU+79;Y-+LVNVM8I[.Q2%IE5@4$KQ
MNL9YW,I'&*^VZ*[,;DU#&Y//)JE2I&A/#T,.ZD5'VG+0=)Q:37+>7LE?2VKM
MT.7"9C5P>8PS*G"$JL*M6JJ<K\C=53C*+L[V2J.VOK?4XGX;6%YI?P]\$Z;?
MVTUG?6'A;0[2[M+A#'/;7-OIUO%-!,A)*212*R.I)(8$$YKXS_;/^'7CKQSJ
MO@>;PCX6UKQ#%8:?J\=Z^EVDMRMH\UY8/$K[$<!ID23:IP2J,>@.?T"HHS3)
MZ.:97+*JM6I3HRC0@ZE-1]I:A*$HM<R<4VX*^FG0,%F%7 X^./IPC.K&567+
M*_*W54E*[6NG,[:Z]3P#XQ^'==UKX!>(/#FD:7>:CKESX9T>U@TNWA:2ZEN8
M)M,:6%8XP6:1!%(S(%X",6 P:Y']D+PEXG\&?#:_TKQ7H6I:!J,GB?4KE+/4
M[=K>9K>2WLECG1652T3LCJC ;6*-W&*^K:*?]D4/[5H9K[2I[:A@98&%/W?9
MN$JCJ.;=N;F3=DKVMTN+Z_4^H5<!R0]G5Q4,7*>O.IPA[-16ZY&M6M[[-)'S
MO^U+X:U[Q;\'=>T3PUI%]K>K7%]H<D&GZ?$9KB5(-6M99F6-%=R(HT,CD*0J
M*6.,9#/V6/#.O^$O@[H>B>)M(O-$U>VU+Q!)-I]_!)!<1Q3ZW?3V[M'(JL!+
M%(LB'D,C!EX-?1=%4\JI/-UG'M:GME@OJ7LO=]GR>U]KSWMS<UU:U^6W2^Q]
M?J?V;_9O)#V2Q?UOVEY<_/[-T^6U^7EL[[7OUL?*G[7_ (0\4>-?AA9Z3X2T
M74==U)/%&F736>FVYN9UMHK74$EF9 RLL:F1%9^0"Z@XR*[WX ^']6T'X->$
M- \0:9=:7J=IIUU!>Z;J$31W%NTFH7CB.:-B2-T3HPY.492#TKVZBB&5489O
M7S?VDW6KX.E@Y4FHNDJ=*HZBDM.;FDW:2ORV6U]13QU2>74LM<8JG2Q-3%1J
M)M5'.I&$'%_9Y4H::<VKUMH?EWXP^#7QG^!OQ U?QM\';2_U'0=3GF>*/2+4
M:G-;V=PR7!TG5M#8O/<6EK-DPW-MO5ECB9C"T*)3KCQ5^U_\8+6X\''PU<Z!
MINJH+75=4.@S^&H%L9#Y=Y!-J6H2R2)%)&"TL=E!]JG#-#$-K'/Z@D9QTX]0
M3_4>W7/TH  SQU))^IZ_G7B/A&E"I6AA,VS7!9?B)U*E;+</7C'#N55WJ*DW
M!U*,)W:E"$DNV[OZBXBJ2C2EB,OR_%8RA"%.EC:])RJI4TE3<XJ485)Q224I
M)[>;/B']E7X1^,OA1XP^)FG>)-.F2REMM&@TK6TAD73=9CBN-0G$EC-)DEDC
MN4%Q#([2V[JL;X 6N,\>_#3Q]J/[6?AWQE9>%-9NO"UKXA\%W-QKD%E*UA##
M8QV(O'>?88S'!L;S7W;4VLI(PPK]$J*ZWPQ@EEV"RRG5KT\-@<=#'4?>C*;E
M"M.O&E*4H_P^:;CMS66YSO/,7+&8K'3C3E7Q>#>#JNSBN65&G1=2*3TFU33M
M\-V]-A ,  #  & >P]..*_//X@_#;QYJ/[7&@^,]/\)ZU=^%K;6/!<TVO6]I
M,=.BCL;*RCNY)+@H8C';,CI(0<1E74X(Q7Z&T5Z&;952S:EAZ-6K4I+#8S#X
MR,J:BY2GAVW&+YDTHRNTVM>S1QX#'5,OG6J4X1FZV%KX62E=)0KQ4927+;WH
MVNEMW5CQ_P"-?POMOBSX$U/PM)(MKJ!:.^T2^<.ZV.K6A+P.X7'[BY5I;:Z5
M<!H)6#;A\A_/OP_J_P"UG\#;:7P=IWA;4K_2K6>>2QCDT&;Q)I4"R3.['3-3
MT\DQ65RP\X6LLSRP2R2?N(Q(U?K)2%0>OY<$$=P00>O?OP,$5Q9IP]3Q^+I9
MAAL=C,KQU.DZ$L3@IQ3K47=QIUJ<XRC44&[QO:WGI;JP&<5,'0EA*V%PN/P<
MJKK+#XJFY*G5<8Q<Z<XRC*+:BN97L_)ZGY1CP!^T5^TEXDT6X^(NGZCH'AO2
MY<SSW^E_V+8V5K-)&;Z/2=+N5AN[W4+J",1B9HVB *;[F/RA%+^H^A:-8>'M
M'TK1-,A%O8:1I]IIME",?NK:TA2"),CC.Q%W8^7(X   K5 (&#CVQTQ^-+6V
M49)1RIXFL\1B<=C<9*#Q.-Q<U.M45./+3IQY5&,*4%?EA%;N[;=K99CFE7,%
M0I^QH87#8925#"X:')2@YN\IN[<IS=DG.3NTN[;?EWQKTC4=>^%/CO2-(L9]
M2U/4/#U];65C:QM+<7,\D>$BBC0%W=N@5023Q@C-> ?L9>!O%_@7PUXQM/%_
MAW4O#UQ?:Y93V<6I020R7,*611I(E=%8QHY"DG.UL@XK[0HK6OE-*OF^"S>5
M6I&K@L/B,/"DN7V<XXGEYI3;7->/*N5)V[HSIYA5I9=B<M4(.EB:]&O*;OSQ
MG1324=>6TE;FNKZ+LK(?\\9_E7YS?!3X9_$'0?VEO$_BK5_"6N:;X=O+CQXU
MOK-S9R1V,Z7^I>;9E)74 B[4+)%R?,50R9!K]&J*>8931S#$Y;BJE6I3EEF)
M>*I1@H.-2;4%RSYDVDN1:QL]6+"XZKA*.-HTXQ<<=0^KU7*]XPYE*\;-+FNE
MJ[V&MTZ$\CH<'J._MU/:OSK^"WPS\>Z%^TUXJ\5:MX1UO3?#MUJ'CZ2VUFYM
MIH["=-0U"XDLGCFD0(PNT</ RMMD5MRY&:_1:BGF&54<QQ&6XBK4J0EEF*^M
MTHP<>6I/D<.2I=-\MG?W;._6P\)F%7!T<=0IQC*&.P_U>KS7O&//&?-'IS7C
M;6ZM<^6_VF_@9<_%_P .6%SH0MX_%GAR2673OM,CPQZC8W,92\TF2= R1O,V
MV6VED4QQ3#_EGN,B_*&E?$W]KWP#9VOA67PCJU[%I21V5M/J7A6[UFY$$:A8
MK=-1TUVBOXX$V)#<JDK,NT2R/@ ?JG32N23@9XZC/J.?3CIC'?->;F/#<<5C
M99A@<PQF4XRK"%/$U<'*-L3"FH1IJK"::E*$(<D9:-)WUUOV8/.I8?"PP6)P
M>$S#"TJDJM&GBH2<J,YWYU3G"49*,FW)QU3EKZ?F/\/O@I\8OC!\1=,^(?QG
MM;FPTG3+JWN3;ZM MO=ZA#93&XL=+L-(.U['3TNCYMP]W&N0LFV*9I_,3Z]_
M:5\.:YXF^#?B;0O#>F7FL:Q=-I(M;&PA,]S,(=6LY9F6)64L$C1I'P3M52V#
MMKWP# _SU[]:6ML)P[A<)@<?@U7Q5:IF<:WUW&UZBGBJTZU/V7.YV45[.&E.
M*CRQ71W;>6(SBOB,9A,4J-"C# NE]5PM&+A0I1I35112NY/GDKSDWS2]$CYG
M_90\+>)/!_PFM-&\4Z1?Z)JB:YJ\[V.H0/;3B&8P&*4Q.2=DFUBC9PV"1SFO
MH76M*L]=TG4M&U")9['5+.XL+R%QN62VNHVAF4C!Y,;MM..&P>U:=%>G@<#2
MP. PV7Q<JU'#8>GAE*M:4ZL*<%"]2R2;DE[UDD<6)Q53$XJMBVE3J5JTZ[Y+
MI0G*3G[K=VN5[-Z]3\HA\.?VA_V;_$VK3_#FQO\ 7_#>I-LAGL=,76[&[MDD
MD>U.I:1%,E[9WUO&=LMR6BB:3<T4A#^76Q<+^UA^T#:?\(EK6ER>%/"URT#:
MM>7.A3^';&>))8YXA<'4'.H:BOF11RBPL(_*#*([J12#7ZAE03G_ !_H1_6E
M P,<?Y/'X_UKYN/!].G&IAJ.<9O1RRI.3>6T\2HT80F^9T:=3D=6-'IR*6J;
M3;9[4N(ZE1QK5,NRVICXQBECYT&ZSE%)>TE#G]E*H[7YI1;3LU8^1?V1O 'B
MKX;^'/&^B>+=)NM+NQXM=K6:=2MMJ5K#8V\"WM@^ MQ:OL!6X&XL28V;]T,?
M#?BG2/&>L?M->,H/AZS1^+[;Q;XBU71W6\CM',^F2/<E8I966)3+"983'.PA
ME5WC.=[9_9F89!_W&'Y[17Y=_#PEOVVM>(''_"0^-H\YZ$6LQSC\^,Y_/CS.
M(LIP^&P7"F3TJM>%"GG6#PU.K&IR8B,;32FJL8Z5(W3YN6[:VNSOR;,JU;%<
M19E.G2=>>5UJLJ?)>A.?M<.W&5._O4Y6=X7M=W6R2N7_ ,8_VR7230SX'U"T
MU%T:S%W;^#+Q[G< 8#=6]P)/L"2L?WHN<R6RE@\:E,.OK?[,'[/_ (F\&:MJ
MGQ(^(T.WQ;JT-U!8V,]P+N^L_M[I<:EJ&I7$,CVPU"_9##A'E:"*23]YF9D3
M[BP!CCI^8%+7N8/AF-'&T,;CLTS'-JF$<I8.&-JPE2P]22Y74C3ITX*51+X9
MRNXO5:I->5B,]G4PU;"X3 8'+J>)2CB986G-5:T$T_9RG.<G&#:UC&R?7J?.
MG[1WP5?XP^#K:UTJ2WM_$_AZXDO] EN]RV\YG2-+S3[F10S117<<4.)"K+'/
M!$[JR%A7QCH/CO\ :]^%NEV_@X^$M9U"UTE!8Z>VH>&Y];:*U@41P0VFJZ:9
MK:YMD0!+??<3.L21@F//E+^K-(0#U (]QW'3\N:TS'ARGB\;+,<'F&.RK&SI
M1HUJN#J)0KPC90=:E-2A*=.*Y83T:5KWL1@LYGAL*L%B,'A<PPD:CJTJ6+A)
MNC.3O-TIPE"<5/2\;VT7F?EIX6^#7QL^//C_ $OQE\8K/4-&\/Z=):O/#J=J
MNGO<65G.LXT;1M(9A/;P7C!_M5[(L<<B.S,]Q.!7Z2^(/#6F>)?#6J>%[^V+
M:9JVESZ3<0@LFVWFA$1*D;>8UVE"IZIMS@FNGHK?*L@PN64,33]I7QM?'RE/
M'XK&3]K6Q;G#D:G;EC&"C>,8Q22BVK,Y\?FE?'5*$^2EAJ>%C&.%P^&BZ=*@
MHR4[P3<I.;DE*4FVVTC\G;/P7^TG^S;KNLV_@?3=0U_PY?W(ECNM/TJ77=*U
M%%)CM[N_L8Y9;[3M12$K#<2!8%9$^1WB"UN7NF_M6?M#PP^&O$VG-X7\+)+'
M=7L]SI$WARQN6MG\VV\Z&\EFO]3)GA1HX+<B*"0K-(RJN:_44C((Z_7I^..U
M & !T^G3\,]J\I<'4HQGA(YOFT<JG*<I9;'$I4N2;O["%10]K"@MN2,[\JLV
M[L]*?$E6<UB99=ETLPC&"6.E1<JW-"R57DE)TG4M>\G%W=FDK1M\I_LC>!O%
M'P_\">)-#\5Z-=Z-J'_"9:A/''=)M6Z@^Q6$(N[20,RSVCR1.L,\>V.4(648
MKH?VCO@F_P 9/"=M;Z9-;V?BG0;I[[0[NZCS#*)$:.ZTRYD'SI;WB[&##*Q3
M112XRN1]&45[E/)<%'*(Y+.$JN"C0^K\LW[_ +-3YXM2BE:<)*+A-6:<4]SS
M)9GBGF7]JPE&EB_;*NG!>XJB23]V5TXR5^:+NGS,_+3PW)^V?X%CTSPK#H_B
M.;1=-DMK.(KINEZ_'#8)-&OEP:LK7$KVT4+3+!YLOF00QPQ(D:HH/W%\>]$U
MGQ+\&/&VBZ/876IZSJ.D1Q6NGVD+SW5S-]LMI#%'"@9RVU"2%!"A2<;17M-%
M<F"X?C@\%C<!+,LQQE#%T'AXO&U8UIX:DZ4Z7+1ER1TY9Z\ZE=QBVS3$YJ\1
MB,+BE@\)AZN'J*K)X>$J:KU%.%3FJIREKS0=N6R2DTD?)?['?@[Q1X*^'6OZ
M7XLT+4?#]_/XRO;R"SU.W:WFEM)-$T&!;A%=59XFFMYXP^"I>.10<J17(_M1
M_L_>*?&6LZ9\2_AN WBG2(8$OM.@E6TO[UM.EBN-,U'3KIW2/[=8F'REMF %
MRIC)=O)6)_N*BM*G#^"K9-1R2O*K4H8>%)4J\9*GB*=2A+GI5X3@DHU(32:L
MK/9IIL<,YQ5/-*F:TU2C7JRFZM-QYZ-2%2/)4I3A)^]3G'1IOLTTTC\M8?C9
M^V+:0Q:/-X-U2>]CA\@W5QX$OFOWD P)FFAD6TG< 9)%FJLV6(.<'T+]G?X!
M>/%\=S?%WXM0W*:P[37NFV&HRK+JDVJWG[I]3U"**>9+(6ENK):6LA#_ +U<
M1PB/!_0;!!XVXXZCGMZ #Z4ZN#"\*J.)PV)S#-\SS;ZG.-;"T<95A[*E5C?E
MJ2A3@O:3C>Z<Y.S2Z)'17SURH8BC@\NP&7_6H>SQ%7#4I>UG!M.4(RJ3G[.+
MM9J*5T>.?&OX56OQ:\#:AX9>2.SOPT=]HE[(ID2QU6V9FAED4,K-#<1M+:W"
M@_ZN<M@^77P%H&I_M8_ BTE\(Z7X7U+4]&LI&6S5]#G\3:7"I9W9M)O[!2T=
MO.29FM92/+=R?*A8E#^L%!&>#R/3L?K75FG#U/,,53S##XW&9;F%.A]6>*P<
MXIU:%TU3JPG&4)*+5XNR:TNVDK88#-Y82A+!UL+A\=@Y5'66'Q*DU3K245*I
M3E"491;44FKVW[L_*#5/"W[3_P"T?J.EV'B_2KS0?#ME<)<.]_I3^']$LI-C
MP37R6ESY=_J=\+>26.!(%G ,DJ;[5<NWZ:>"?"EEX)\+Z'X6TW/V+0].MM/@
M)R#)Y*#S)V&<!YYFEF<<_-(>>,GJ\8_S_GZ45>3Y!1RJKB,7+%8O'X_%QA&O
MC,;44ZCIP4>6E3A&,84J:<5+EBKWW=B,PS6KCZ=##QHT,)A,,Y2HX;#1<::G
M-OGG)R;E.<D[.4GHMM0KX*_X*3_&7XC?!3]CSXQZY\(O!WC/QM\6/$?AN]\!
M_#G2_ V@:KXAU>P\3^,;>;1K3Q-)::59WMS%9>$X+BZ\033O$L+RV%O:&:-[
MB-J^]:C:-792RJP&?O+DY[8.<#&3G@YSQBOJ\OQ-+!9A@L96P\,92PF*HXBI
MA*DG"GBHT:D:CH5)I2E&G4Y>6;C%OE;5CY_'X:KB\%B\+1Q$\)5Q.'K8>&)@
ME*>'=:#A[:G%V3J4T^:%VDI:W/\ *ZN?V+OVQ9KFYGF_9B_:!N9[B>6>>Y;X
M6>,Y)III7:21YI)-%B$K[F(,RF0S-ND=@6YA'[%G[80((_9<_: !'(S\)_%S
M#(Z9']E<CU'?I7^J688_[BC\!_4&D,$9!&T<C'W5_JI'YC%?TE'Z3N<Q22X5
MRQ6V2Q^)44KJR2^KO1)M;Z[OK;\&_P")?LKO=\1YF]F[X7#:OW;W?.W=M-MZ
MZJ_77^53_@W+_8,\<_"6\^,G[3'QM^'.O^"/%>IQVGPO^&NC>-?#]WH>O:=H
MT.S5_&^O0V>I6\%XD&L7K:)HMG>R1B62#2]4BBE,%W<HW]5X    P   !T '
M 'X4U$5!@*HZ]% SD]?E &3_ !8')^@I]?@_&'%..XRX@QW$&80IT:V+]C&&
M&I.3HX6A0HPHTZ%)R][D2@YMO652<Y-)R/V3A;AS!\*Y)A,EP3E.EA5)SK32
MC4Q%:I)RJUZJCHJE1M72=DHQ2LD%%%%?,GT(4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% #6)"L1V!/TP#ST/Z\5^7W[5?QK^*7AGXEZOX.\/^++
MS1=!MM.T>6.VTRWL[6X,EW:>?.S:@MK_ &BX=VX07?EJ!\JKDU^H+ D8'K_C
M7Y+_ +5W@W5-7^-6MW]K/IZ0S:1H(5;B2X64>79;3N5+250,\C#G(ZXKX_CB
M>+AD?^PU:M&O+%48.=&M*A/DDI)ISC*#<>\;V?5'TG"L,+/-H_6Z<*M*.'JR
M49TXU(J:<.62C*,M5=V=KKHU>Y\DZKK6K:]<&[UO5M1U:Y;),VI7]U>2 L2S
M;3/-)LRQ)PF .@P *R]D8&.,=>6)//7DG//?GGC/05W!^'&O9/\ IFD_]_KO
M^EA1_P *XU__ )_-)_[_ -W_ /(%?ALL!F%27-4A[23LW*=:$I2?NV;E*;;>
MN[?Y:_K4,9@J<5"G-P@M%&-.44EILE%+OT_X/#>7$.@4?0X'Y XJ3(]1^8KM
M?^%<:_\ \_FD_P#?^[_^0*/^%<:__P _FD_]_P"[_P#D"I_L['?\^8]/^7E/
MKR_WO/\ JVK^NX3_ )^2_P#!<O+R]?ZWXK(]1^8HR/4?F*[7_A7&O_\ /YI/
M_?\ N_\ Y H_X5QK_P#S^:3_ -_[O_Y H_L['?\ /F/3_EY3Z\O][S_JVI]=
MPG_/R7_@N7EY>O\ 6_%9'J/S%&1ZC\Q7:_\ "N-?_P"?S2?^_P#=_P#R!1_P
MKC7_ /G\TG_O_=__ "!1_9V._P"?,>G_ "\I]>7^]Y_U;4^NX3_GY+_P7+R\
MO7^M^*R/4?F*,CU'YBNU_P"%<:__ ,_FD_\ ?^[_ /D"C_A7&O\ _/YI/_?^
M[_\ D"C^SL=_SYCT_P"7E/KR_P![S_JVI]=PG_/R7_@N7EY>O];\5D>H_,49
M'J/S%=K_ ,*XU_\ Y_-)_P"_]W_\@4?\*XU__G\TG_O_ '?_ ,@4?V=CO^?,
M>G_+RGUY?[WG_5M3Z[A/^?DO_!<O+R]?ZWXK(]1^8HR/4?F*[7_A7&O_ //Y
MI/\ W_N__D"C_A7&O_\ /YI/_?\ N_\ Y H_L['?\^8]/^7E/KR_WO/^K:GU
MW"?\_)?^"Y>7EZ_UOQ61ZC\Q1D>H_,5VO_"N-?\ ^?S2?^_]W_\ (%'_  KC
M7_\ G\TG_O\ W?\ \@4?V=CO^?,>G_+RGUY?[WG_ %;4^NX3_GY+_P %R\O+
MU_K?BLCU'YBC(]1^8KM?^%<:_P#\_FD_]_[O_P"0*/\ A7&O_P#/YI/_ '_N
M_P#Y H_L['?\^8]/^7E/KR_WO/\ JVI]=PG_ #\E_P""Y>7EZ_UOQ61ZC\Q1
MD>H_,5VO_"N-?_Y_-)_[_P!W_P#(%'_"N-?_ .?S2?\ O_=__(%']G8[_GS'
MI_R\I]>7^]Y_U;4^NX3_ )^2_P#!<O+R]?ZWXK(]1^8HR/4?F*[7_A7&O_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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@H **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
